Atopic Dermatitis (DBCOND0028414)

Identifiers

Synonyms
Dermatitis, Atopic / Atopic Eczema / Dermatitis, Atopic Dermatitis / Dermatitis, Eczematous / Dermatitis, Dermatitis Atopic / Eczema, Atopic / Atopic Dermatitis Eczema / Eczema / Atopic Dermatitis (AD) / Dermatitis atopic / Atopic Dermatitis (Eczema) / Eczema Atopic Dermatitis / Atopic dermatitis / Eczematous dermatitis / Atopic dermatitis, unspecified / Atopic neurodermatitis / Eczema allergic / Allergic dermatitis / Dermatitis allergic / Eczema atopic / Atopic neurodermatitis (disorder) / Allergic eczema / Atopic dermatitis (disorder) / Localised eczema / Localized eczema / Dermatitis, unspecified / Eczema NOS / Eczema [Ambiguous] (disorder) / Eczematous rash / Dermatitis eczematoid

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Aloe vera leaf
Indicated for use as a topical agent to soothe sensitive skin and to relieve symptoms of various skin conditions, including contact or atopic dermatitis, eczema, dermatitis and acne urticata, first-...
Azathioprine
An immunosuppressant used to prevent renal transplant rejection, treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis.
Bendazac
A non-steroidal anti-inflammatory drug (NSAID) available as an eye drop for the treatment of cataracts and as a topical cream for the treatment of dermatitis, eczema, hives, skin ulcers and other inflammatory skin conditions.
Betamethasone
A systemic corticosteroid used to relieve inflammation in various conditions, including but not limited to allergic states, dermatologic disorders, gastrointestinal diseases, and hematological disorders.
Clioquinol
An antifungal cream used to treat a variety of fungal infections.
Clobetasone
A corticosteroid used to treat dry eyes, eczema, and dermatitis.
Corticotropin
A diagnostic agent used in the screening of patients presumed to have adrenocortical insufficiency.
Cortisone acetate
A steroid hormone used for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses and endocrine disorders associated with inadequate production of steroid hormones.
Cyclosporine
A steroid-sparing immunosuppressant used in organ and bone marrow transplants as well as inflammatory conditions such as ulcerative colitis, rheumatoid arthritis, and atopic dermatitis.
Desoximetasone
A glucocorticoid used to treat inflammatory and pruritic corticosteroid-responsive dermatoses.
Dexamethasone
A glucocorticoid available in various modes of administration that is used for the treatment of various inflammatory conditions, including bronchial asthma, as well as endocrine and rheumatic disorders.
Doxepin
A psychotropic agent used for the treatment of depression, anxiety, manic-depressive disorder, and insomnia.
Flumethasone
A corticosteroid used to treat contact dermatitis, atopic dermatitis, eczema, psoriasis, diaper rash, and other skin conditions.
Fluocinolone acetonide
A corticosteroid used to treat skin conditions, eczematous otitis externa, diabetic macular edema, and non-infectious uveitis of the posterior segment of the eye.
Hydrocortisone
A glucocorticoid used to treat corticosteroid-responsive dermatoses, endocrine disorders, immune conditions, and allergic disorders.
Hydrocortisone acetate
A corticosteroid used to treat inflammatory and pruritic corticosteroid-responsive dermatoses and ulcerative colitis.
Hydrocortisone butyrate
A corticosteroid used to treat inflammatory and pruritic corticosteroid-responsive dermatoses.
Ichthammol
Ichthammol is also referred to as ammonium bituminosulfonate or ammonium bituminosulphonate. It is an ammonium salt of dark sulfonated shale oil (bituminous schists) produced via distillation of the oil followed...
No drug targets
Light mineral oil
An oil used to hydrate dry, itchy skin, hemorrhoids, and dry eyes.
No drug targets
Meclocycline
A tetracycline antibiotic indicated in the treatment of susceptible skin infections, bacterial vaginitis, vulvovaginitis, and cervicitis.
Mepyramine
An antihistamine agent used for the symptomatic treatment of allergy, hypersensitivity reactions, and pruritic skin disorders.
Methylprednisolone
A corticosteroid used to treat inflammation or immune reactions across a variety of organ systems, endocrine conditions, and neoplastic diseases.
Methylprednisolone aceponate
A corticosteroid indicated in the treatment of corticosteroid-responsive dermatoses.
No drug targets
Neomycin
An aminoglycoside antibiotic agent used orally and topically to treat a wide variety of infections in the body.
Oxatomide
An antihistamine indicated in the treatment and prevention of allergic symptoms.
Peanut oil
A compound used to lubricate ear wax, as an emollient, and used in laxatives.
No drug targets
Pheniramine
An antihistamine used to treat allergic rhinitis and pruritus.
Phenol
An antiseptic and disinfectant used in a variety of settings.
Pine tar
A medication indicated in itchy, inflamed, and flaky skin conditions.
No drug targets
Prednisolone
A glucocorticoid used to treat adrenocortical insufficiency, inflammatory conditions, and some cancers.
Prednisone
A corticosteroid used to treat inflammation or immune-mediated reactions and to treat endocrine or neoplastic diseases.
Roflumilast
A selective phosphodiesterase-4 inhibitor indicated to decrease the risk of exacerbations in patients with severe chronic obstructive pulmonary disease (COPD) and to treat skin conditions such as plaque psoriasis and atopic dermatitis.
Salicylic acid
An acid used to treat acne, psoriasis, calluses, corns, keratosis pilaris, and warts.
Titanium dioxide
A sunscreen agent found in sunscreens that absorbs UV rays.
Triamcinolone
A glucocorticoid used to treat a wide variety of inflammatory conditions of organ systems and tissues.
Urea
A keratolytic emollient used to treat hyperkeratotic lesions and moisturize the skin.
Zinc oxide
A mineral ingredient of various pharmacological preparations to treat diaper dermatitis and other skin conditions, to protect the epidermis, and to prevent sunburn.
No drug targets
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT06554847
Evaluation of 611 in Combination With Topical Corticosteroid in Participants With Moderate to Severe Atopic DermatitisNo drug interventionstreatment3recruiting
NCT05250115
A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic DermatitisNo drug interventionsNot AvailableNot Availablerecruiting
NCT05999799
A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants with Moderate to Severe Atopic DermatitisNo drug interventionstreatment2recruiting
NCT06248814
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic DermatitisNo drug interventionstreatment1recruiting
NCT06353087
Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)No drug interventionsNot AvailableNot Availablerecruiting
NCT03085303
Treatment of Atopic Dermatitis by a Full-Body Blue Light DeviceNo drug interventionstreatmentNot Availablecompleted
NCT04086121
A Study to Test the Long-term Safety of BI 655130 in Patients With Atopic Eczema Who Took Part in Study 1368-0032treatment2terminated
NCT01011621
Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive Dermatosistreatment3unknown_status
NCT04185584
Long-Term Safety Follow-Up Study of SCM-AGH in Subjects Who Participated and Administered SCM-AGH in to Severe Atopic Dermatitis Clinical TrialsNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT06094179
Evaluate the Safety, Tolerability of BAT6026treatment1 / 2recruiting
NCT01828879
An Efficacy and Safety Study of Tacrolimus Ointment in Adult Participants With Atopic Dermatitistreatment4completed
NCT02655679
An Ascending Multiple Dose Study of VTP-38543 in Adult Participants With Mild to Moderate Atopic DermatitisNo drug interventionstreatment1 / 2completed
NCT02277743
Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitistreatment3completed
NCT04365387
A Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumabtreatment2completed
NCT04617977
Integrative Body-Mind-Spirit Intervention for Families With Children Suffering From EczemaNo drug interventionstreatmentNot Availableunknown_status
NCT03634345
Drug Drug Interaction Study Evaluating the Effect of Fluvoxamine or Fluconazole on PK and Safety of PF-04965842.basic_science1completed
NCT01381445
A Study Assessing GW870086's Potential to Cause Skin Thinningother1completed
NCT03868098
Different Application Rates of Crisaborole Ointment 2% in Adults With Mild to Moderate Atopic Dermatitistreatment4completed
NCT02634905
A Multicenter Randomized Control Trial in Children With Moderate to Severe Atopic Dermatitis to Assess the Benefit of a Nurse-led One-to-one Education Program in Addition to Standard Care Compared to Standard Care Alone on the Long Term Control of Disease Severity at 6 MonthsNo drug interventionssupportive_careNot Availableterminated
NCT03672383
Functional Study to Investigate the Efficacy of a New Medical Device (Modified Diprobase Formulation)No drug interventionstreatmentNot Availablecompleted
NCT02343783
A Study to Evaluate Use of Induced Skin Blisters in Adult Participants With Atopic Dermatitis, Allergic Asthma and Atopic Healthy ParticipantsNo drug interventionstreatment0completed
NCT03798561
Study to Evaluate ASN008 Topical Gel (TG)No drug interventionstreatment1completed
NCT02615561
Curing Atopic Dermatits in Children With a Commerical Medical Device and Maintaining Healthy Skin by Using a New Cosmetic ProductNo drug interventionstreatmentNot Availablecompleted
NCT00671528
Safety and Efficacy of Quadriderme® in the Treatment of Impetiginous Eczema (Study P05134AM4)treatment4terminated
NCT02910011
Topical NanoDox® for Atopic Dermatitistreatment2completed
NCT00560378
Long-term Safety of Protopic in Atopic Eczematreatment3completed
NCT04761978
Efficacy and Tolerance of JAK Inhibitors in ATU for Atopic DermatitisNo drug interventionsNot AvailableNot Availableunknown_status
NCT03754309
A Study of KY1005 in Patients With Moderate to Severe Atopic Dermatitistreatment2completed
NCT02739009
First in Human of Single and Multiple Doses of MOR106No drug interventionstreatment1completed
NCT01772056
Efficacy Study of Topical Twice Weekly Fluticasone Treatment to Reduce Relapse in Atopic Dermatitis in Childrenprevention3terminated
NCT01652885
Safety, Tolerability, and PK of AN2728 in Adolescents With Atopic Dermatitistreatment1 / 2completed
NCT04011215
Wool Clothing for the Management of Childhood Atopic Dermatitis (DESSINE2)No drug interventionstreatmentNot Availablerecruiting
NCT03822832
A Study in Patients With Atopic Eczema to Test How Effective BI 655130 is and How Well it is Toleratedtreatment2completed
NCT00689832
Protopic Ointment in Children Atopic Eczematreatment4completed
NCT03808532
Moisturizer to Prevent Atopic DermatitisNo drug interventionsprevention2withdrawn
NCT02466152
Pharmacokinetic Study of Topical GSK2894512 Creamtreatment1completed
NCT00666159
Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitistreatment4completed
NCT02906475
Atopic Dermatitis in Atopy Predisposed InfantsNo drug interventionspreventionNot Availablecompleted
NCT04878770
NMF-CsA-Dupi TrialtreatmentNot Availablerecruiting
NCT06488742
The Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in Patients With Atopic DermatitisNo drug interventionstreatmentNot Availablerecruiting
NCT03722706
Improving Therapeutic Patient Education for Atopic Dermatitis: Evaluation of a Parent HandbookNo drug interventionsotherNot Availablecompleted
NCT03568136
Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitistreatment2completed
NCT05149313
A Study of Lebrikizumab in Combination With Topical Corticosteroids in Participants Having Atopic Dermatitis (AD) That Are Not Adequately Controlled or Non-eligible for Cyclosporinetreatment3completed
NCT01063218
Evaluation of Cetaphil Advanced Usage to Control Light to Moderate Atopic Dermatitis, in Attempt to Reduce the Necessity of Topic Corticoids ApplicationNo drug interventionsprevention4completed
NCT01497119
A Study of JNJ-39758979 in Adult Japanese Patients With Moderate Atopic Dermatitistreatment2terminated
NCT01602341
Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitistreatment2completed
NCT01631617
Effects of Treatments on Atopic Dermatitistreatment2recruiting
NCT00189917
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in Patients With Atopic Disordersprevention1completed
NCT03346434
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL)treatment2 / 3completed
NCT05004324
Safety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD)No drug interventionstreatment3unknown_status
NCT00480896
Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointmenttreatment3completed
NCT03422822
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitistreatment3active_not_recruiting
NCT02182557
WAL 801 CL Dry Syrup in Paediatric Atopic Dermatitis Patientstreatment3completed
NCT00226057
Efalizumab for Moderate to Severe Atopic Dermatitistreatment1completed
NCT00267826
Immunopharmacological Effects of Rituximab in Atopic DermatitistreatmentNot Availablecompleted
NCT00560326
Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitistreatment2completed
NCT02118766
Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitistreatment3completed
NCT01326520
Effect of Dietary Phospholipids on Atopic DermatitisNo drug interventionstreatmentNot Availablecompleted
NCT00817076
Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Allergic Skin Inflammation (P03475)treatment3completed
NCT02317276
A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawaltreatment4terminated
NCT03349060
Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitistreatment3completed
NCT00667160
Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitistreatment4completed
NCT04179760
Safety and Efficacy of SCM-AGH in Subjects With Moderate to Severe Atopic DermatitisNo drug interventionstreatment1 / 2completed
NCT05078294
Results in Real Clinical Practice of Treatment of Moderate-severe Atopic DermatitisNo drug interventionsNot AvailableNot Availablerecruiting
NCT02411162
A Single Dose Phase I Exploratory Study in Healthy Volunteers With GSK2894512 Creambasic_science1completed
NCT00691262
Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitistreatment3completed
NCT03233529
Crisaborole Ointment 2% Skin Biomarker Biopsy Study in Atopic Dermatitisbasic_science2completed
NCT02627989
An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switched to Ointment (W/O Emulsion) Formulation of Very Strong Class Topical CorticosteroidsNot AvailableNot Availablecompleted
NCT03901144
A NOVel Moisturiser for Atopic Dermatitis: Effect on the Skin Barriertreatment2completed
NCT03183440
Efficacy Of Antenatal Maternal Supplementation With GOS/Inulin Prebiotics On Atopic Dermatitis Prevalence In High-Risk One-Year-Old ChildrenNo drug interventionspreventionNot Availableunknown_status
NCT02534467
Does Treatment With Montelukast Improve Symptoms of Atopic Dermatitis in Children?treatment4completed
NCT03627767
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjectstreatment3completed
NCT04635072
Stabilized Whole Rice Bran (SWRB) for Mild to Moderate Atopic Dermatitistreatment0completed
NCT05023668
China Atopic Dermatitis Registry StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT04599946
Goat Infant Formula Feeding and Eczema (the GIraFFE Study)No drug interventionspreventionNot Availableactive_not_recruiting
NCT03428646
Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD)Not AvailableNot Availableactive_not_recruiting
NCT00185510
Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitistreatment4completed
NCT01737710
Atopic Dermatitis Research Network (ADRN) Influenza Vaccine StudypreventionNot Availablecompleted
NCT01447381
Systemic Therapies for Pediatric Atopic DermatitisNo drug interventionsNot AvailableNot Availableunknown_status
NCT03139981
A Study To Evaluate ASN002 In Subjects With Atopic Dermatitistreatment1completed
NCT03055195
Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitistreatment2terminated
NCT03345914
Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)treatment3completed
NCT00541255
A Long-Term Examination of Asthma From Childhood Through AdolescenceNo drug interventionsNot AvailableNot Availablecompleted
NCT04081350
A Study of LY3471851 in Participants With Eczemabasic_science1completed
NCT00159523
Impact in Off-spring of Mothers After Perinatal Daily Intake of a ProbioticNo drug interventionspreventionNot Availablecompleted
NCT02595008
Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Atopic DermatitisNo drug interventionstreatment2completed
NCT05486208
A Study of LY3844583 in Healthy Participants and Participants With Atopic DermatitisNo drug interventionsbasic_science1terminated
NCT00534508
Distribution of Tacrolimus in Skin, Atopic Dermatitistreatment2completed
NCT05590338
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic of GSK1070806 After a Single Intravenous Dose in Healthy Male and Female Caucasian, Chinese and Japanese Participants Aged 18 to 65 Years of Age InclusiveNo drug interventionstreatment1completed
NCT05226143
A Study of an Eczema Spot Treatment in Providing Eczema Symptoms Relief and Lasting Itch Relief to Affected Skin AreaNo drug interventionstreatmentNot Availablecompleted
NCT00146003
Efalizumab for Eczematreatment2completed
NCT01920464
Place of Flixovate® in the Treatment Pathway and Its Conditions of Use in Infants Aged From 3 to 12 Months Between 2010 and 2012 by French GPs and Private PaediatriciansNo drug interventionsNot AvailableNot Availablecompleted
NCT00152464
Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)treatment3completed
NCT02866864
Animal Allergy in Korean Veterinary ResearcherNo drug interventionsNot AvailableNot Availablecompleted
NCT00666302
A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitistreatment4completed
NCT06173284
Evaluation of 611(Recombinant Humanized Anti-interleukin-4 Receptor Alpha IgG4 Monoclonal Antibody) in Chinese Adults With Moderate to Severe Atopic DermatitisNo drug interventionstreatment3recruiting
NCT04065633
Study of Commercial and Phase 3 of PF-04965842 Formulations, Estimation of Effect of Food on Commercial FormulationNo drug interventionsother1completed
NCT00277433
Histamine Pharmacogenetics in Children With Atopic DermatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT00837551
Phase IIa Study of WBI-1001 Cream for Atopic Dermatitistreatment1 / 2completed
NCT00691145
Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitistreatment3completed
NCT05450198
Multiple Rising Dose Study of MK-6194 in Participants With Atopic Dermatitis (MK-6194-008)No drug interventionstreatment1completed
NCT00690105
Protopic Ointment in Adult Atopic Eczema of the Facetreatment4completed
NCT02343861
The Effectiveness of Tailored Messages on the Usage of Emollient in Patients With Atopic DermatitisNo drug interventionstreatmentNot Availablecompleted
NCT05391061
A Study to Learn About the Study Medicine (Called Cibinqo) in People With Atopic DermatitisNot AvailableNot Availablerecruiting
NCT03054428
Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitistreatment3completed
NCT02534428
Wool Clothing for the Management of Childhood Atopic DermatitisNo drug interventionstreatmentNot Availablecompleted
NCT03907228
Study to Evaluate the Use of RHT-3201 in SCORAD Reduction in Young Patients With Atopic DermatitisNo drug interventionstreatmentNot Availableunknown_status
NCT04220411
A Study for AR100DP1 in Mild to Moderate Atopic Dermatitis (AD)treatment1 / 2terminated
NCT02576093
Safety, Tolerability, Pharmacokinetics and Efficacy of WOL071-007 in Atopic Dermatitis PatientsNo drug interventionstreatment1completed
NCT03059693
Efficacy and Tolerability of HAT1 in Patients With Moderate to Severe Atopic DermatitisNo drug interventionstreatment1 / 2completed
NCT03575871
Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitistreatment3completed
NCT02582788
Bathing Additives in Pediatric Atopic DermatitisNo drug interventionstreatmentNot Availableterminated
NCT02916888
A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and SpecialistsNo drug interventionsNot AvailableNot Availablecompleted
NCT01691209
Efficacy/Safety Study to Explore a New Topical Formulation in Atopic DermatitisNo drug interventionstreatmentNot Availablewithdrawn
NCT04684485
To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic DermatitisNo drug interventionstreatment2active_not_recruiting
NCT04800315
A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitistreatment2completed
NCT00523952
Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patientstreatment3completed
NCT05094700
A Study of a Polymeric Surfactant Technology Cleanser in Sensitive Skin ParticipantsNo drug interventionsotherNot Availablecompleted
NCT04938700
Study on the Correlation Between Intestinal Microecology and Allergic Diseases in ChildrenNo drug interventionstreatment4unknown_status
NCT02286700
Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic Dermatitistreatment3unknown_status
NCT03720470
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapytreatment3completed
NCT02182570
WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis Patientstreatment3completed
NCT02835170
Study of Autologous Total Immunoglobulin G Therapy for Atopic DermatitisNo drug interventionstreatment2 / 3completed
NCT00356642
Study Of Single And Ten Day Repeat Atopical Applications Of GW842470X Cream On The Skin Of Patients With Atopic DermatitisNo drug interventionstreatment1completed
NCT02115399
ADRN Barrier/Immunoprofiling Exploratory Pilot StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT06447506
Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis.No drug interventionstreatment2not_yet_recruiting
NCT02637206
Skin Irritation Study of GSK2894512 Creamtreatment1completed
NCT04791319
A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic Dermatitistreatment2terminated
NCT06553417
Emollient 'Plus' vs Urea 10% for Mild-Moderate Atopic DermatitisNo drug interventionstreatmentNot Availablecompleted
NCT01098734
Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Creamtreatment2completed
NCT03042624
Efficacy of Fermented Rice Flour for the Treatment of Atopic Dermatitis: Randomized, Double-blind Controlled TrialNo drug interventionstreatmentNot Availableunknown_status
NCT00106496
A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitistreatment4completed
NCT00616096
Study of Immunoadsorption to Treat Severe Atopical Dermatitis Associated With Excessively High Serum IgE LevelsNo drug interventionstreatmentNot Availablecompleted
NCT05641558
Evaluation of 611 in Chinese Adult Patients With Moderate-to-Severe Atopic DermatitisNo drug interventionstreatment1 / 2completed
NCT02713035
Behavioral Self-Help Intervention for Pediatric Atopic Dermatitis and Eczema PatientsNo drug interventionstreatmentNot Availableterminated
NCT00846235
Effect of Moisturising Creams on Skin Moisture in Atopic DermatitisNo drug interventionstreatment4completed
NCT02585986
Intervention Study to Evaluate a Probiotic in Mild Atopic Dermatitis Young PatientsNo drug interventionstreatmentNot Availablecompleted
NCT01945086
A Study of Ustekinumab (STELARA®) in Adult Japanese Participants With Severe Atopic Dermatitistreatment2completed
NCT00673725
Locobase® REPAIR Used as an Adjunctive to Standard Therapy in Children With Moderate to Severe Atopic DermatitisNo drug interventionstreatment4completed
NCT03252730
In-Use Test With a Cosmetic ProductNo drug interventionstreatmentNot Availablecompleted
NCT03563066
Effect of Benralizumab in Atopic Dermatitistreatment2completed
NCT05870865
A Study to Evaluate the Anti-pruritic Effectiveness of ASN008 in Adults With Mild to Moderate Atopic DermatitisNo drug interventionstreatment2completed
NCT06526182
A Study of of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitistreatment3recruiting
NCT02900131
Efficacy, Safety and Dose Finding Trial of Topical Jaungo Application in Atopic Dermatitis PatientsNo drug interventionstreatment2completed
NCT03663673
Effect of Different Skin Creams on TEWLtreatment1completed
NCT00459576
Risk of Asthma in Infants With Atopic DermatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT05544591
Evaluation of 611 in Chinese Adults With Moderate to Severe Atopic DermatitisNo drug interventionstreatment2completed
NCT00535691
Tacrolimus Ointment Pharmacokinetics in Infants With Atopic Dermatitistreatment2completed
NCT01673529
Investigation of Topical SB705498 on Healthy VolunteersNo drug interventionstreatment1completed
NCT01782729
An Efficacy and Safety Study of Tacrolimus Ointment in Pediatric Participants With Atopic Dermatitistreatment4completed
NCT02590289
A Pharmacokinetic Study to Evaluate BBI-5000 Capsules and Food Effect in Healthy Adult SubjectsNo drug interventionstreatment1completed
NCT04740892
A Study of a Moisturizing Cream and Baby Wash in the Management of Mild to Moderate Atopic Dermatitis in Infants, Toddlers and ChildrenNo drug interventionstreatmentNot Availablecompleted
NCT02118792
Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitistreatment3completed
NCT05177744
Toxicity of Micro and Nano Plastics Combined With Environmental Contaminants on the Risk of Allergic DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT04990440
A Study of Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitistreatment2terminated
NCT02680301
Topical Steroid Formulation and Wet Wrapstreatment4completed
NCT01948869
Efficacy/Safety Study to Explore a New Revised Topical Formulation in Atopic DermatitisNo drug interventionstreatmentNot Availablecompleted
NCT02277769
Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitistreatment3completed
NCT00257569
Study Of Atopic Dermatitis In Pediatricstreatment3completed
NCT02028546
The Effect of Bathing and Moisturizers on Skin Hydration in Atopic Dermatitis: an in Vivo StudyNo drug interventionstreatmentNot Availablecompleted
NCT06324812
Evaluation of 611 in Chinese Children and Adolescents With Moderate to Severe Atopic Dermatitistreatment1 / 2not_yet_recruiting
NCT04440410
Evaluation of Cutaneous and Circulating Inflammatory Biomarkers in Hidradenitis Suppurativa and Atopic DermatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT01299610
A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebotreatment2completed
NCT00480610
Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus Ointmenttreatment3completed
NCT00354510
Topical GW842470X In Adults Patients With Moderate Atopic DermatitisNo drug interventionstreatment2completed
NCT02001181
Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema)treatment2completed
NCT00121381
Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitistreatment4completed
NCT05674695
Spanish Academy of Dermatology and Venereology Registry of Atopic Dermatitis TherapyNot AvailableNot Availablerecruiting
NCT04760314
A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitistreatment3completed
NCT02732314
Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitistreatment4completed
NCT02564055
A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD)treatment2completed
NCT03096223
A Phase 1 Study of KHK4083 in Subjects With Atopic Dermatitistreatment1completed
NCT01301508
Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-Moderate Atopic Dermatitistreatment2completed
NCT05639738
Assessment of Clinical, Biological and Biometrological Paramaters in Adult Subjects Suffering From ADNo drug interventionsotherNot Availableterminated
NCT05014438
A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitistreatment2completed
NCT04975438
Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic DermatitisNo drug interventionstreatment1completed
NCT03750643
A Study of LY3454738 in Healthy Participants and Participants With Atopic DermatitisNo drug interventionstreatment1completed
NCT06585202
Study of ATI-2138 in Adult Participants with Moderate to Severe Atopic DermatitisNo drug interventionstreatment2recruiting
NCT02504853
Natural History and Genetics of Food Allergy and Related ConditionsNo drug interventionsNot AvailableNot Availablerecruiting
NCT05081557
A Study to Assess Real-World Use, Safety, and Effectiveness of Oral Upadacitinib in Adult and Adolescent (>=12 Years Old) Participants With Atopic DermatitisNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05139836
A Study to Assess Disease Activity in Adolescent and Adult Participants With Atopic Dermatitis Who Receive Oral Upadacitinib Tablets in a Real-World SettingNo drug interventionsNot AvailableNot Availablerecruiting
NCT05375955
A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.treatment2completed
NCT05394792
An Observational Study of Upadacitinib to Assess Change in Disease Activity in Canadian Adult Participants With Moderate-to-Severe Atopic Dermatitis Who Are Inadequate Responders To or Discontinuing DupilumabNo drug interventionsNot AvailableNot Availablecompleted
NCT05509023
Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)No drug interventionstreatment2active_not_recruiting
NCT05669794
An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real WorldNo drug interventionsNot AvailableNot Availablerecruiting
NCT05958407
A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapytreatment3recruiting
NCT06627335
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database AnalysisNot AvailableNot Availablerecruiting
NCT06096857
Cardamom and Topical Roseomonas in Atopic Dermatitistreatment2recruiting
NCT06169527
A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving DupilumabNot AvailableNot Availablerecruiting
NCT06224192
A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe ADtreatment3recruiting
NCT06238817
A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitistreatment3recruiting
NCT06389136
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumabtreatment3recruiting
NCT06395948
A Study Evaluating APG777 in Atopic DermatitisNo drug interventionstreatment2recruiting
NCT06436183
A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitistreatment2recruiting
NCT06438263
A Study to Evaluate Bioavailability of Rocatinlimab Autoinjector and Vial in Healthy Participantstreatment1recruiting
NCT06461897
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitistreatment3recruiting
NCT04864886
Metabolic Profiling of Immune Responses in Immune-mediated DiseasesNo drug interventionsNot AvailableNot Availablerecruiting
NCT05155085
A Study to Assess Subcutaneous Lirentelimab (AK002) in Atopic Dermatitistreatment2terminated
NCT05375929
A Study to Learn About Abrocitinib Tablets in People With Atopic Dermatitis in Indiatreatment3completed
NCT05387980
A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.Not AvailableNot Availablerecruiting
NCT05388760
Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)treatment2active_not_recruiting
NCT05500794
Meditation in Inflammatory DermatosisNo drug interventionsotherNot Availablerecruiting
NCT05559359
A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitistreatment3recruiting
NCT05704738
A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD)treatment3active_not_recruiting
NCT05721937
A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their OffspringNot AvailableNot Availablerecruiting
NCT05724199
A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)treatment3active_not_recruiting
NCT05819463
Treatment and Medical Care of Patients with Moderate-to-severe Atopic Dermatitis - TREATswitzerlandNo drug interventionsNot AvailableNot Availablerecruiting
NCT05844618
Short-Term Efficacy of Triamcinolone Acetonide (Aristocort® C) in Subjects with Atopic Dermatitistreatment4recruiting
NCT05882877
A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)treatment3recruiting
NCT05891119
Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitisbasic_science0active_not_recruiting
NCT05899816
A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER)basic_science3active_not_recruiting
NCT05923099
A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic DermatitisNo drug interventionstreatment2active_not_recruiting
NCT06176040
A Study of TAVO101 in Atopic Dermatitis PatientsNo drug interventionstreatment2recruiting
NCT06268860
A Study to Assess Bioavailability of Rocatinlimab (AMG 451) Vial and Prefilled Syringe in Healthy Participantstreatment1completed
NCT06280716
A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitistreatment3recruiting
NCT06300697
Michigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics ProjectNo drug interventionsbasic_scienceNot Availablerecruiting
NCT06311682
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitistreatment3recruiting
NCT06363461
Study of TDM-180935 in Atopic Dermatitis PatientsNo drug interventionstreatment2active_not_recruiting
NCT06390722
A Study to Assess the Effect of Upadacitinib in Atopic Dermatitis-induced Sleep Disturbance in Adults With Moderate to Severe Atopic Dermatitistreatment3withdrawn
NCT06397781
Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patientstreatment4not_yet_recruiting
NCT06397911
Evaluate Efficacy, Pharmacokinetics, and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitistreatment2recruiting
NCT06421740
An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in ChinaNo drug interventionsNot AvailableNot Availablerecruiting
NCT06455891
MYCobiome Analysis in Atopic Dermatitis With Head and Neck InvolvementNo drug interventionsNot AvailableNot Availablerecruiting
NCT06464133
Investigation of Filaggrin Gene Mutations Among Latinx Patients With Atopic DermatitisNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT06564389
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and PatientsNo drug interventionstreatment1not_yet_recruiting
NCT06587685
A Study to Assess the Efficacy and Safety of PG-011 Gel in Adolescents and Adults With Atopic DermatitisNo drug interventionstreatment3recruiting
NCT06614907
A PhaseⅠ Comparative Study to Evaluate the Pharmacokinetics of QL2108 to Dupixent®treatment1recruiting
NCT06599411
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin DiseasesNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05372003
IL-4 and Insulin Resistance for Treatment of Patients With Atopic Dermatitistreatment0completed
NCT00510003
Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-oldtreatment4completed
NCT04498403
A Study of the Long-Term Safety of Crisaborole Ointment, 2% in Japanese Pediatric and Adult Participants With Mild to Moderate Atopic Dermatitistreatment3terminated
NCT06032403
Patient With Atopic Dermatitis' Needs for Self-management Support - Flexible Patient Centred ConsultationsNo drug interventionssupportive_careNot Availablerecruiting
NCT00389103
Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD)prevention1withdrawn
NCT05369403
A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumabtreatment3active_not_recruiting
NCT03775590
The Role of Bathing Additives in the Treatment of Pediatric Atopic DermatitisNo drug interventionstreatmentNot Availableterminated
NCT05443490
Clinical Trial to Evaluate the Effect of a Probiotic Mixture in the Treatment of Atopic Dermatitis in ChildrenNo drug interventionstreatmentNot Availablerecruiting
NCT03198390
Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin ConditionsNo drug interventionsNot AvailableNot Availableterminated
NCT05092464
Exploratory Study to Evaluate the Application of NLAC Cream in Adults With Atopic DermatitisNo drug interventionstreatmentNot Availableunknown_status
NCT01960764
Examination of Whether Host Preconditioning Modifies Short-term Transplant Survivaltreatment1withdrawn
NCT03688464
Treatment of Nighttime Pruritus in Atopic Dermatitistreatment0withdrawn
NCT01856764
Topical Roflumilast in Adults With Atopic Dermatitistreatment2completed
NCT05527964
A Study to Evaluate the Quality of Life of Male and Female Adult Patients With Severe Refractory Atopic Dermatitis Treated With Dupilumab in Czech RepublicNo drug interventionsNot AvailableNot Availablerecruiting
NCT04525521
Hand Sanitizer Effects on the Skin BarrierNo drug interventionsNot AvailableNot Availableunknown_status
NCT05098821
Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune ModulationNo drug interventionsNot AvailableNot Availablerecruiting
NCT05718921
A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy VolunteersNo drug interventionstreatment1completed
NCT06085521
A Study of LNK01001 Capsule in Patients With Moderate to Severe Atopic DermatitisNo drug interventionstreatment2completed
NCT05803902
An Evaluation of 9MW1911 Injection in Healthy SubjectsNo drug interventionstreatment1active_not_recruiting
NCT01785602
Efficacy and Safety Study of QAW039 in the Treatment of Patients With Moderate to Severe Atopic Dermatitis.treatment2completed
NCT03297502
Safety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic Dermatitistreatment3completed
NCT03461302
Efficacy of Topical Coal Tar in Children With Atopic Dermatitistreatment4unknown_status
NCT00557284
Efficacy Study of Montelukast in Atopic Dermatitis Induced by Food Allergenstreatment4completed
NCT04419584
Evaluate the Efficacy of Using Modified Qing-Ying Decoction in Atopic Dermatitis ChildrenNo drug interventionstreatment2 / 3unknown_status
NCT05694884
Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With DupilumabNo drug interventionstreatment2recruiting
NCT05984784
A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD)No drug interventionstreatment1 / 2terminated
NCT03157284
Efficacy of Fermented Rice Flour for the Treatment of Atopic DermatitisNo drug interventionstreatmentNot Availablecompleted
NCT04008784
Improvement of Short Term Outcome of Mild to Moderate Atopic Dermatitis Using a Combination of Crisaborole and a Concomitant Topical Corticosteroid Over a 8 Week PeriodNot AvailableNot Availablecompleted
NCT00815984
Fractional Exhaled Nitric Oxide (FeNO) Result Prediction Factors in Children With Allergic DiseasesNo drug interventionsNot AvailableNot Availablecompleted
NCT04798079
Systems Biology of Early AtopyNo drug interventionsNot AvailableNot Availablerecruiting
NCT02552979
Atopy Patch Test in Children With Atopic DermatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT01132079
Pimecrolimus and Epidermal Barrier FunctionNo drug interventionsbasic_scienceNot Availablecompleted
NCT02094287
Placebo Effect in the Treatment of Atopic DermatitistreatmentNot Availablecompleted
NCT03962387
Evalution the Safety and Efficacy in Atopic Dermatitis PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT02334787
A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male Subjectstreatment1completed
NCT04965233
Using a Telemedicine Approach in a Genome-wide Association Study of Atopic Dermatitis - Searching for Novel Biomarkers in Clinically Relevant PhenotypesNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00125333
Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitistreatment1 / 2completed
NCT03676933
Efficacy and Steroid Sparing Potential Study of DGLA Cream in Early Childhood Patients With Moderate to Severe Atopic Dermatitistreatment2completed
NCT00690833
Efficacy of Desonide (Desonatetm) Gel 0.05% in Younger and Older Subjects With Atopic Dermatitistreatment4completed
NCT05099133
A Trial to Evaluate Pharmacokinetics, Immunogenicity, Safety, and Tolerability of LEO 138559 in Healthy Japanese SubjectsNo drug interventionstreatment1completed
NCT05178433
Skin Care Strategies for Neonatal Jaundice Phototherapy to Prevent Atopic Dermatitis in Moderate and Severe InfantsNo drug interventionspreventionNot Availableunknown_status
NCT05732454
A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injectiontreatment2 / 3terminated
NCT03047954
Broncho-Vaxom (OM 85 BV) in Children Suffering From Atopic Dermatitisprevention3completed
NCT04392154
Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)treatment3active_not_recruiting
NCT03175354
A Study in Subjects With Moderate Atopic Dermatitistreatment2completed
NCT05932654
POC Study to Evaluate BSI-045B Monotherapy and BSI-045B add-on Therapy With Dupilumab in Atopic Dermatitistreatment2recruiting
NCT05026554
Characterization of Chronic Hand EczemaNo drug interventionsNot AvailableNot Availablerecruiting
NCT03363854
Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3treatment3completed
NCT02176551
Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric SubjectsNo drug interventionstreatment3withdrawn
NCT02098551
Skin Testing With Recombinant Bet v 1 and Hypoallergenic Recombinant Bet v 1 FragmentsNo drug interventionsNot AvailableNot Availablecompleted
NCT04664153
Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasistreatment2completed
NCT04969653
The Incidence of Venous Thromboembolism in Atopic DermatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT03188653
Evaluating the Effects of Cleansers on the SkinNo drug interventionstreatmentNot Availableterminated
NCT05783453
CLINICAL EFFICACY OF EMOLLIENTS IN ATOPIC DERMATITIS PATIENTSNo drug interventionsNot AvailableNot Availablecompleted
NCT06463353
Clinical Study of Trilinolein Cream for Prevention of Relapse in Remission of Moderate-to-severe Atopic Dermatitis.No drug interventionspreventionNot Availablenot_yet_recruiting
NCT03562377
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)treatment2completed
NCT03351777
Efficacy and Safety of PR022 Topical Gel to Treat Mild-to-Moderate Atopic DermatitisNo drug interventionstreatment2unknown_status
NCT03490877
Scratch and Sleep Quantification in Atopic DermatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT02176577
Study to Determine the Pharmacokinetics of Product 0405No drug interventionstreatment3withdrawn
NCT00117377
Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitistreatment4completed
NCT00515047
Identifying Genetic Determinants of Eczema Herpeticum and Other Viral Infections in Individuals With Atopic DermatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT01053247
Study of 0416 Ointment in the Treatment of Atopic Dermatitistreatment3completed
NCT02475447
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitistreatment2completed
NCT05286047
Probiotic on Atopic Dermatitis in InfantNo drug interventionstreatmentNot Availablerecruiting
NCT01064947
Safety and Efficacy Study of Altabax Ointment in the Treatment of Secondarily Infected Atopic Dermatitistreatment4completed
NCT01995747
The Effect of Anti-CεmX on IgE ProductionNo drug interventionsNot AvailableNot Availablecompleted
NCT05442645
A Study in Male and Female Adult Patients With Atopic Dermatitis Treated With Dupilumab in TaiwanNo drug interventionsNot AvailableNot Availablecompleted
NCT02031445
Double-Blind, Trial to Evaluate the Safety and Efficacy of MRX-6 Cream 2%No drug interventionstreatment2terminated
NCT05671445
The Study of CM326 in Adult Subjects With Atopic DermatitisNo drug interventionstreatment2recruiting
NCT04195698
Open-Label Extension Study of Upadacitinib in Adult Participants With Moderate to Severe Atopic Dermatitistreatment3completed
NCT00991198
The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of PhotodamageNo drug interventionstreatment2completed
NCT01756898
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic DermatitisNo drug interventionstreatment2completed
NCT00475605
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic DermatitisNo drug interventionsNot AvailableNot Availableterminated
NCT01927705
Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis (AD)No drug interventionstreatment1 / 2completed
NCT03587805
Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTENDtreatment3completed
NCT05704205
The UPDATE Trial (Uvb Phototherapy in Dermatology for ATopic Eczema)No drug interventionstreatmentNot Availablerecruiting
NCT02680405
Identification of Epidermal Signatures in Patients With Atopic DermatitisNo drug interventionsNot AvailableNot Availableunknown_status
NCT05186805
Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitistreatment2completed
NCT03824405
Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic DermatitisNo drug interventionstreatment2completed
NCT04214197
Study of Crisaborole Ointment 2% in Mild to Moderate Atopic Dermatitistreatment4unknown_status
NCT01428297
A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrometreatment1completed
NCT00696397
Comprehensive Investigation of Opiates, Neuropeptides, Barrier Function, Scratching and Sleep PhysiologyNo drug interventionsNot AvailableNot Availablecompleted
NCT01992497
Cesarean Section StudyNo drug interventionssupportive_careNot Availablecompleted
NCT03484897
Soothing and Barrier Restoration Activity of a Body Cream for Atopic SkinNo drug interventionstreatmentNot Availablecompleted
NCT00460083
Epiceram Versus Elidel for Treatment of Mild to Moderate Atopic Dermatitistreatment4completed
NCT02945683
Effects of Lactobacillus Reuteri Plus Vitamin D3 in Children With Atopic DermatitisNo drug interventionssupportive_careNot Availablecompleted
NCT03619161
Bleach vs. Bubbles: Assessing the Impact of the Bathroom Environment on EczemaNo drug interventionstreatmentNot Availablecompleted
NCT01138761
Health Literacy for Children With Atopic Dermatitis and Their CaregiversNo drug interventionshealth_services_researchNot Availableterminated
NCT04556461
Effects of Tralokinumab Treatment of Atopic Dermatitis on Skin Barrier Functionbasic_science2completed
NCT01577628
Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic DermatitispreventionNot Availableterminated
NCT00200928
Asthma, a Disease Due to a Lack of Bacterial Infections in Childhood.No drug interventionspreventionNot Availablecompleted
NCT05177328
Targeted Investigation of Microbiome EliminationNo drug interventionstreatment1terminated
NCT00883311
A Study of BRT-FC-83C for the Treatment of Atopic DermatitisNo drug interventionstreatment2completed
NCT02270411
Inflammatory Cells From Various PathologiesNo drug interventionsNot AvailableNot Availablecompleted
NCT00931411
Tolerance and Efficacy of Formulation 609580 20 Versus Formulation 609209 in Children With Atopic DermatitisNo drug interventionstreatmentNot Availableterminated
NCT01408511
HPA Axis Study in Adultstreatment2completed
NCT03921411
A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Participants With Atopic Dermatitis (AD)treatment2completed
NCT03315611
Study to Assess the Effect of "Eucerin AtopiControl" on Dermal Symptoms in Patients With Atopic DermatitistreatmentNot Availablecompleted
NCT00232011
Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitistreatment3completed
NCT00367393
Reconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic Dermatitistreatment4completed
NCT01692093
KM110329 in Adult Patients With Atopic DermatitisNo drug interventionstreatment2unknown_status
NCT02748993
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitistreatment1 / 2completed
NCT02925793
Safety and Efficacy Study of Topically Applied DS107 Cream in Mild to Moderate Atopic Dermatitis Patients (AD)No drug interventionstreatment2completed
NCT06174493
Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical TrialsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00693693
Adherence to Topical Hydrocortisone 17-butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic Dermatitistreatment4completed
NCT05992493
The Role of Human Milk Oligosaccharides and Microbiomes on Infantile Colic and Atopic Dermatitis in Term InfantsNo drug interventionsNot AvailableNot Availablerecruiting
NCT01759693
Platelet Activation in Chronic Inflammatory Skin DiseasesNo drug interventionsNot AvailableNot Availableunknown_status
NCT02743871
Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic DermatitisNo drug interventionstreatment1completed
NCT05277571
A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermatitis (Part B)No drug interventionsbasic_science1 / 2recruiting
NCT03002571
Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects (301)No drug interventionstreatment3completed
NCT00605878
Studies of Skin Microbes in Healthy People and in People With Skin ConditionsNo drug interventionsNot AvailableNot Availablerecruiting
NCT05383378
A First-In-Human Study to Evaluate the Safety, Tolerability, and Efficacy of Si-544 in Adults With Atopic DermatitisNo drug interventionstreatment1completed
NCT00946478
Effect of Pimecrolimus Cream on Cathelicidin Levels in Subjects With EczematreatmentNot Availablecompleted
NCT02401178
The Role of Filaggrin and FADS Genes on the Concentrations of PUFA Towards Its Effect on Atopic Dermatitis in InfantsNo drug interventionsNot AvailableNot Availablecompleted
NCT02077088
Effect of Galactooligosaccharides on Incidence of Atopic Manifestations in InfantsNo drug interventionspreventionNot Availablecompleted
NCT01859988
Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitistreatment2completed
NCT05531188
Efficacy Evaluation and Cutaneous Acceptability of the Lipikar Med Product on Subjects With Atopic DermatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT05932888
Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult SubjectsNo drug interventionstreatment1completed
NCT00819507
VANOS Cream and Skin Barrier Functiontreatment4completed
NCT04354207
Vitamin D and Its Receptor Gene Polymorphisms in Lithuanian, Latvian and Taiwanese Patients With Atopic Dermatitis and AsthmaNo drug interventionsNot AvailableNot Availableunknown_status
NCT02691507
Trial to Determine the Therapeutic Benefit of an OTC Cream on Dry, Itchy Skin of Adults and Children With Eczematreatment2completed
NCT05530707
Evaluation of Acceptability, Skin Barrier Restoration and Balance of Atopic Skin Using MoisturizerNo drug interventionspreventionNot Availablecompleted
NCT05602207
Effects of Abrocitinib in Subjects With Atopic Dermatitis With an Unsatisfactory Response After Treatment With Dupilumabtreatment4recruiting
NCT00690807
A Phase 2 Study of PH-10 for the Treatment of Atopic DermatitisNo drug interventionstreatment2completed
NCT00124709
Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modificationtreatment4terminated
NCT05019209
Skin Responses and T Cell Immunology After House Dust Mite Exposure in Sensitized Atopic Dermatitis PatientsNo drug interventionsbasic_scienceNot Availablecompleted
NCT05904509
Insulin Resistance in Atopic Dermatitis PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT06553209
Study of CM512 in Healthy Subjects and Patients With Atopic DermatitisNo drug interventionstreatment1not_yet_recruiting
NCT00891709
LEO 29102 Single and Multiple Dose Study by Dermal ApplicationNo drug interventionsNot Available1completed
NCT05059509
Evaluate Efficacy of FB825 in Adults With Atopic Dermatitistreatment2completed
NCT05048056
Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic DermatitisNo drug interventionstreatment2unknown_status
NCT05461456
Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1%treatment1completed
NCT06058156
Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic DermatitisNo drug interventionstreatment2recruiting
NCT02519556
Trial on Effectiveness Combined Probiotics in Atopic Dermatitis in Childrentreatment4completed
NCT05071456
Electrochemistry Measurement of Skin Hydration ParametersNo drug interventionsotherNot Availableunknown_status
NCT06469385
Topical ENS-002 for Atopic Dermatitis in AdultsNo drug interventionstreatment1recruiting
NCT03160885
Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)treatment3completed
NCT04772885
A Single and Multiple Ascending Dose Trial of KT-474 in Healthy Adult Volunteers and Patients With Atopic Dermatitis (AD) or Hidradenitis Suppurativa (HS)No drug interventionstreatment1completed
NCT01232985
Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in AdultsNo drug interventionstreatment2completed
NCT04339985
Study to Evaluate Safety & Efficacy of Topical ATx201 OINTMENT in Adolescents and Adults With Mild to Moderate ADNo drug interventionstreatment2completed
NCT05525715
A Study of QY201 Tablet in Subjects With Moderate to Severe Atopic DermatitisNo drug interventionstreatment1 / 2not_yet_recruiting
NCT04297215
The Effectiveness of Antibacterial Therapeutic Clothing Based on Silver or Chitosan as Compared With Non-antibacterial Therapeutic Clothing in Patients With Moderate to Severe Atopic DermatitisNo drug interventionstreatmentNot Availableunknown_status
NCT03553615
Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitistreatment2withdrawn
NCT05099315
Microbiome in Atopic Dermatitis Under Systemic TherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00129415
Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin ConditionsNo drug interventionstreatment1 / 2terminated
NCT03257215
Can Vitamin D Treatment Help Treat Moderate to Severe Atopic Dermatitis in Young Children? The D-Vex Pilot Studytreatment4suspended
NCT01368315
CT 327 in the "Atopy Patch Test" Modelbasic_science1withdrawn
NCT00298337
Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008prevention2 / 3unknown_status
NCT05330637
Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China.No drug interventionsNot AvailableNot Availablerecruiting
NCT05970432
A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic DermatitisNo drug interventionstreatment2recruiting
NCT01675232
A Study Comparing the Efficacy of Two Topical Steroid Application Regimens in Pediatric Patients With Atopic DermatitisNo drug interventionstreatmentNot Availablecompleted
NCT06465732
Efficacy and Safety of Dupilumab in Combination With Tofacitinib in Moderate to Severe Adult AD Patientstreatment4not_yet_recruiting
NCT00944632
Dose Escalation of Different Concentrations of ZK 245186 in Atopic Dermatitistreatment2completed
NCT02844452
Antipruritic Effect of Acupuncture in Patients With Atopic DermatitisNo drug interventionstreatmentNot Availablecompleted
NCT02068352
A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitistreatment2completed
NCT05318300
Evaluation of an Adapted Formula on Atopic Dermatitis.No drug interventionstreatmentNot Availableactive_not_recruiting
NCT03428100
A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisabletreatment3completed
NCT05240300
A Study of Topical BX005-A in Subjects With Moderate to Severe Atopic DermatitisNo drug interventionstreatment1 / 2unknown_status
NCT05098600
The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech RepublicNo drug interventionsNot AvailableNot Availablecompleted
NCT05032859
Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)treatment3completed
NCT01149759
Reversal of Epidermal Phenotype in Severe Atopic Dermatitis With Cyclosporine TherapytreatmentNot Availablecompleted
NCT00179959
The Impact of Treating Staphylococcus Aureus Infection and Colonization on the Clinical Severity of Atopic Dermatitistreatment4completed
NCT06275659
An Exploratory Study to Evaluate a Digital Intervention to Disrupt Scratching in Atopic Dermatitis and PsoriasisNo drug interventionsbasic_scienceNot Availableactive_not_recruiting
NCT04706559
Efficacy of Oral Supplementation of Probiotics in Children With Atopic DermatitistreatmentNot Availablecompleted
NCT03735459
Eczema Reminder and Accountability ProgramNo drug interventionstreatmentNot Availablecompleted
NCT03747575
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitistreatment2completed
NCT00076375
Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in Atopic Dermatitis (Eczema)treatment2completed
NCT03559075
Clinical vs. Anecdotal Evidence - Pediatric Atopic DermatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT06415175
Study in Paediatric Patients With Atopic Dermatitis Treated With Dupilumab in SpainNot AvailableNot Availablenot_yet_recruiting
NCT04193670
Sensory Nociceptive Nerve Fibers, Key Regulator of Immune Response Type 2 in Atopic DermatitisNo drug interventionshealth_services_researchNot Availablecompleted
NCT06108570
Evaluation of the Efficacy of TOPIALYSE Baume Protect+ on Atopic DermatisNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03375970
Establishing the Collaborative Care Model of Traditional Chinese Medicine and Western Medicine-Pediatric Atopic DermatitisNo drug interventionstreatmentNot Availableunknown_status
NCT03304470
A Study to Evaluate the Safety and Efficacy of ATx201 in Subjects With Moderate Atopic DermatitisNo drug interventionstreatment2completed
NCT01494142
Registry for the Atopic Dermatitis Research NetworkNo drug interventionsNot AvailableNot Availablecompleted
NCT01538342
Role of Tyrosine Kinase Lyn and Cleaved Form by Caspases in PsoriasisNo drug interventionsbasic_scienceNot Availablecompleted
NCT04413942
Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic Dermatitistreatment2unknown_status
NCT02144142
Evaluation of the Kinetic Properties of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patientstreatment2withdrawn
NCT04486742
Brief Cognitive Behavioral Therapy to Treat Itch Rumination "Itch CBT" in EczemaNo drug interventionstreatmentNot Availablecompleted
NCT04162899
A Phase II Study in Adult Patients With Moderate to Severe Atopic Dermatitistreatment2completed
NCT02286999
Probiotic Supplementation in Breastfed Newborn Infantsprevention1withdrawn
NCT05018806
Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitistreatment2completed
NCT02465606
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitistreatment2completed
NCT00236106
Short Term Growth in Children With Atopic DermatitisNot Available4completed
NCT01897506
Assessing Risk of Food Insecurity Within Households of Children With Food AllergyNo drug interventionsNot AvailableNot Availablecompleted
NCT01850849
Safety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO 39652 CreamNo drug interventionsNot Available1completed
NCT02376049
A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)treatment1completed
NCT04186949
Early Origins of Allergy and AsthmaNo drug interventionsNot AvailableNot Availablecompleted
NCT01202149
Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic DermatitisNo drug interventionstreatment4completed
NCT02755649
A Study to Assess the Efficacy and Safety of Dupilumab in Participants With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA Because it is Not Medically Advisabletreatment3completed
NCT06182436
Virtual Reality for Pain Management During Dupilumab InjectionNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03676036
Efficacy and Steroid Sparing Potential Study of DGLA Cream in Patients With Moderate to Severe Atopic Dermatitistreatment2completed
NCT04725136
Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic DermatitisNo drug interventionstreatment1 / 2unknown_status
NCT04936113
Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Previously Enrolled in the FB401-01 StudyNo drug interventionstreatment2terminated
NCT05062213
A Clinical Trial to Evaluate the Safety and Efficacy of a Moisturizer Body Lotion in Adults of Atopic Dermatitis.No drug interventionsbasic_scienceNot Availablecompleted
NCT01959113
Validation of the Short-term Antimicrobial Action of Transplanted BacteriaNo drug interventionstreatment1completed
NCT04192513
Observer-Blinded Dose Escalating, Single Dose to Study Safety and Antimicrobial Efficacy of Gel vs. PlaceboNo drug interventionstreatment2terminated
NCT02965118
CAPTAIN-AD: Clinical Study of AmorePacific's TRPV1 Antagonist in Atopic Dermatitistreatment3completed
NCT00368719
Evaluation to Assess the Long Term Safety of Tacrolimus Ointment for Atopic Dermatitistreatment4withdrawn
NCT05583019
Atopic Dermatitis With Accelerometry and Polysomnography (ADAP)No drug interventionsNot AvailableNot Availablecompleted
NCT01789619
Extended Release Tacrolimus (Advagraf®) in Severe Adult Atopic Dermatitis PatientsNot AvailableNot Availablecompleted
NCT01461941
A Phase 2 Study of E6005 in Patients With Atopic Dermatitistreatment2completed
NCT05439941
A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous EDP1815 Trialstreatment2terminated
NCT06039241
Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years With Atopic DermatitisNo drug interventionsNot AvailableNot Availablerecruiting
NCT04984941
Evaluation of the Role of IgE Responses to Der p 1 and Der p 2 in Chinese House Dust Mite-Allergic PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT04447417
Dupilumab Skin Barrier Function Study in Atopic Dermatitistreatment4completed
NCT02925117
A Study to Evaluate ABT-494 (Upadacitinib) in Adults With Moderate to Severe Atopic Dermatitistreatment2completed
NCT02211417
Oral DS107 in Moderate to Severe Atopic Dermatitistreatment2completed
NCT01660217
Eczema Action Plan Improves Patient and Caregiver Understanding and Perception of Atopic Dermatitis ManagementNo drug interventionssupportive_careNot Availablecompleted
NCT05969717
Induced Pluripotent Stem Cell Derived Exosomes for the Treatment of Atopic DermatitisNo drug interventionstreatment0recruiting
NCT02340234
A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitistreatment2completed
NCT01638234
Effectiveness of Melatonin for Sleep Disturbances in Children With Atopic DermatitisNo drug interventionstreatment2 / 3completed
NCT03775434
A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic DermatitisNo drug interventionstreatment1completed
NCT05868824
Dynamic Blood Inflammatory Profile in Atopic Dermatitis Patients (ADAMUNE)No drug interventionsbasic_scienceNot Availablerecruiting
NCT04730024
Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD InjNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03822624
Study to Evaluate the Use of a Probiotic in SCORAD Reduction in Young Patients With Atopic DermatitisNo drug interventionstreatmentNot Availableunknown_status
NCT04358224
The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatmenttreatment4completed
NCT00879424
Vitamin D Supplementation in Childhood Atopic DermatitisNo drug interventionstreatmentNot Availablecompleted
NCT05859724
Evaluation of NM26-2198 in Healthy Subjects and in Patients With Moderate-to-severe Atopic Dermatitis (AD)No drug interventionstreatment1recruiting
NCT03443024
A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitistreatment2completed
NCT06144424
Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Atopic DermatitisNo drug interventionstreatment2completed
NCT05222516
Immunomodulation by OM-85 (Broncho-Vaxom) in Early ADtreatment2terminated
NCT04562116
A Study to Assess the Effects of Nemolizumab on Cytochrome P450 Substrates in Participants With Moderate-to-Severe Atopic Dermatitisbasic_science2completed
NCT00367016
Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)treatment4completed
NCT04265716
Topical L. Reuteri in Children With Atopic DermatitisNo drug interventionssupportive_careNot Availableunknown_status
NCT00958516
Assessment of the Phototoxic Potential of LEO 29102 CreamNo drug interventionsNot Available1completed
NCT03758716
An Open-Labeled Exploratory Study to Evaluate Safety and Efficacy of FB825 in Adults With Atopic Dermatitistreatment2completed
NCT03585296
A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitistreatment2completed
NCT00795496
Bronchial Hyperreactivity in Atopic Dermatitis Patients - a 10 Year Follow-upNo drug interventionsNot AvailableNot Availablecompleted
NCT03334396
A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitistreatment3completed
NCT03915496
Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitistreatment2completed
NCT03954158
Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥2 Years With Mild to Moderate Atopic Dermatitistreatment2completed
NCT01356758
Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic AgentsNot AvailableNot Availablecompleted
NCT04836858
A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.No drug interventionstreatment2completed
NCT01393158
Apremilast for Atopic Dermatitis - A Pilot Study in Adultstreatment2completed
NCT00119158
Combination Therapy for Atopic Dermatitistreatment4completed
NCT03050658
Bathing Babies and AllergyNo drug interventionsNot AvailableNot Availableunknown_status
NCT03051958
Internet-based Mindfulness and Exposure Treatment for Atopic DermatitisNo drug interventionstreatmentNot Availablecompleted
NCT01779258
Emollients in the Management of Atopic Dermatitistreatment3completed
NCT01447758
Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.No drug interventionstreatment1terminated
NCT01337635
Vitamin D Deficiency and Atopic DermatitistreatmentNot Availableterminated
NCT00980135
Sinecort Pilot Efficacy StudyNo drug interventionstreatment2completed
NCT06035835
Probiotics and Breastmilk Decrease Risk of Atopic Dermatitis in Premature InfantsNot AvailableNot Availablecompleted
NCT06477835
A Study to Evaluate the Efficacy and Safety of SIM0718 in Adult and Adolescent Patients With Moderate to Severe Atopic DermatitisNo drug interventionstreatment3not_yet_recruiting
NCT00371163
Molecular and Cellular Characterization of Spongiotic DermatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT06551363
Atopic Dermatitis Cutaneous Discomfort of the Infant Under the Age of One Year : Analysis of Filmed Sequences (PRE-PRURINEO)No drug interventionsNot AvailableNot Availablecompleted
NCT05487963
Tolerability and Effectiveness of CGB-500 Topical Ointment, 1% Tofacitinib, for the Treatment of Atopic Dermatitistreatment1 / 2unknown_status
NCT04146363
Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1)treatment3completed
NCT03622463
A Trial of Antroquinonol in Patients With Atopic Dermatitistreatment2completed
NCT00919763
Efficacy and Safety Study of CD2027 Ointment 3 Microgram Per Gram (mcg/g) Twice Daily Treatment for Adults With at Least Moderate Atopic DermatitisNo drug interventionstreatment2completed
NCT05523986
Vitamin D Treatment Effect for Atopic Dermatitis in ChildrenNo drug interventionstreatmentNot Availablerecruiting
NCT05952986
A Study to Evaluate the Safety and Bridging PK Profile of FB825 for Single Subcutaneous Administration in Healthy Adultstreatment1active_not_recruiting
NCT02058186
Effect of Oral Vitamin D Supplement on Atopic Dermatitis; A Clinical Trial With Staphylococcus Aureus Colonization DeterminationtreatmentNot Availablecompleted
NCT03610386
Effects of an Anti-TRPM8 in the Atopic Dermatitis PruritusNo drug interventionstreatmentNot Availablecompleted
NCT04539639
Clinical Study of Jaktinib in the Treatment of Patients With Moderate and Severe Atopic Dermatitistreatment2completed
NCT03142139
Does Timeliness of DTaP-IPV-Hib Vaccination Affect Development of Atopic Dermatitis Before 1 Year of Age?No drug interventionsNot AvailableNot Availablecompleted
NCT04154839
Epidemiological Survey and Genetic Analysis of AD Patients in Hong KongNo drug interventionsNot AvailableNot Availableunknown_status
NCT03607422
A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2)treatment3active_not_recruiting
NCT00438022
Identifying Risk Factors for Eczema Herpeticum in Individuals With Atopic DermatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT06427122
Effect of EMD Protocol for Urge on Dermatology-specific Quality of LifeNo drug interventionstreatmentNot Availablerecruiting
NCT05526222
A Phase III Study of Jaktinib in Adults With Moderate and Severe Atopic Dermatitistreatment3recruiting
NCT05034822
Study of Ruxolitinib Cream in Children With Atopic Dermatitistreatment1completed
NCT05934422
NiPPeR Randomised Trial - Child Follow Up StudyNo drug interventionspreventionNot Availableenrolling_by_invitation
NCT01223222
A Study to Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin Infectiontreatment2completed
NCT03725722
Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.treatment2completed
NCT03381625
Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque PsoriasisNo drug interventionstreatment2completed
NCT00884325
Management of Pruritus With Xyzal in Atopic Dermatitistreatment4completed
NCT02302625
Cognitive Behavior Therapy for Atopic DermatitisNo drug interventionstreatmentNot Availablecompleted
NCT05579925
A Study of CM310 in Children Patients With Moderate-to-severe Atopic Dermatistreatment2recruiting
NCT02103725
A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic DermatitisNot Available1completed
NCT05790330
Mind and Skin - the Neurocutaneous Axis in Atopic EczemaNot AvailableNot Availablerecruiting
NCT00925730
Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusiontreatment4completed
NCT03293030
Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitistreatment4completed
NCT02193230
Taking Into Account the Patient/Parent Preference in the Galenic Choice in Atopic Dermatitis. Feasibility and Impact on Treatment AdherenceNo drug interventionsNot AvailableNot Availablecompleted
NCT05969730
Baricitinib Versus Azathioprine in Patients With Moderate-to-Severe Atopic DermatitistreatmentNot Availablerecruiting
NCT04815148
MH004 Topical Cream in Healthy Adult Volunteers and Participants With Atopic Dermatitis or Rheumatoid ArthritisNo drug interventionstreatment1unknown_status
NCT01861548
Polish Mother and Child Cohort Study (REPRO_PL) - Follow up of the Children.No drug interventionsNot AvailableNot Availablecompleted
NCT04274348
Staphylococcal Toxins in Atopic Dermatitis and Eczema HerpeticumNo drug interventionsbasic_scienceNot Availableunknown_status
NCT04900948
Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of Lifeprevention4completed
NCT05544448
In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory DiseasesNo drug interventionsbasic_scienceNot Availableunknown_status
NCT04643457
A Study to Test the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants and in Study Participants With Atopic DermatitisNo drug interventionsbasic_science1completed
NCT00801957
Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic Dermatitistreatment2completed
NCT03645057
ASPIRE: PROs & Caregiver Burden in Children With Atopic Dermatitistreatment3completed
NCT03531957
Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)treatment2completed
NCT02945657
Pharmacokinetics and Safety of MM36 Topical Ointment in Pediatric Subjects With Atopic Dermatitistreatment2completed
NCT01808157
A Study to Evaluate the Efficacy, Safety and Tolerability of CT327 in Atopic Dermatitistreatment2completed
NCT05409326
A Study of TQH2722 Injection to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Immunogenicity in Healthy Adult SubjectsNo drug interventionstreatment1unknown_status
NCT03981926
Team-Based Connected Health (TCH) to Improve Clinical Outcomes and Access in Atopic DermatitisNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT04444726
Phototherpy Versus Tapwater Iontophoresis for Management of Atopic Dermatitis in Children.treatmentNot Availablecompleted
NCT06499766
Methodological Study of the Effect of a Lotion Containing Nature Based Microbial Extract on Atopic SkinNo drug interventionsotherNot Availablecompleted
NCT03388866
Effect of Sublingual Immunotherapy in Patients With Atopic DermatitisNo drug interventionstreatment4completed
NCT03661866
A Longitudinal Observational Study of Patients Undergoing Therapy for IMISCNo drug interventionsNot AvailableNot Availablerecruiting
NCT05635266
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesNo drug interventionsNot AvailableNot Availablerecruiting
NCT04668066
Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic DermatitisNo drug interventionsbasic_science1completed
NCT03517566
A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic DermatitisNo drug interventionstreatment2terminated
NCT06444165
Lebrikizumab Pen Ease of Use in Participants With Atopic Dermatitisother3completed
NCT04306965
Apremilast 30 mg Twice Daily (BID) Combined With Dupilumabtreatment2completed
NCT05638165
A Single-center, Randomized, Double-blinded, Placebo-controlled, Phase 1 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of NCP112No drug interventionstreatment1completed
NCT04738565
An Innovative Probiotic Product With Antiallergic PropertiesNo drug interventionstreatmentNot Availablecompleted
NCT06116565
A Study of CM310 in Subjects With Moderate-to-Severe Atopic Dermatitistreatment2not_yet_recruiting
NCT06277765
Study of CM310 Injection in Adolescent Subjects With Atopic Dermatistreatment3not_yet_recruiting
NCT06238765
CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness RegistryNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT05916365
Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participant With Moderate-to-Severe Atopic Dermatitistreatment3active_not_recruiting
NCT00932074
A Study to Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD)No drug interventionstreatment1 / 2completed
NCT04256174
A Study of AK120 (IL-4Rα) in Healthy Subjects and Subjects With Moderate- to- Severe Atopic DermatitisNo drug interventionsother1completed
NCT06055374
A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Repeated-dose SC Injection in Patients With Moderate to Severe Atopic DermatitisNo drug interventionstreatment1withdrawn
NCT06022874
The Therapeutic Effects of Topical Cannabidiol (CBD) Products for Atopic DermatitisNo drug interventionsNot AvailableNot Availablerecruiting
NCT02241174
0.005% Sodium Hypochlorite Final Rinse Solution in Atopic Dermatitistreatment1withdrawn
NCT03496974
A Phase II Study of Bermekimab (MABp1) in Patients With Moderate to Severe Atopic Dermatitistreatment2completed
NCT04950374
A Clinical Trial to Evaluate the Safety and Efficacy of a Moisturizer Body Lotion and a Lip Moisturizer in Adults of Atopic Dermatitis.No drug interventionsbasic_scienceNot Availablewithdrawn
NCT00820820
IDA (Immunothérapie de la Dermatite Atopique) Adult - Immunotherapy in Atopic DermatitisNo drug interventionsbasic_scienceNot Availablecompleted
NCT03873220
Monitoring Of Scratch Via Accelerometry In ChildrenNo drug interventionsNot AvailableNot Availablecompleted
NCT06552520
To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic DermatitisNo drug interventionstreatment3not_yet_recruiting
NCT03571620
Safety and Efficacy Study of Q301 in Mild to Moderate Adolescents and Adults Atopic Dermatitis PatientsNo drug interventionstreatment2completed
NCT05090982
Creation of a Shared Medical Decision-making Tool for Atopic DermatitisNo drug interventionsNot AvailableNot Availableunknown_status
NCT03928431
Restoration of Microbiota in NeonatesNo drug interventionstreatmentNot Availablerecruiting
NCT03568331
Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)treatment3completed
NCT01007331
Probiotic Bacteria to Infants With Atopic DermatitisNo drug interventionssupportive_careNot Availablecompleted
NCT00721331
A Phase I Study to Assess the Safety and Tolerability of Topical CRx-197 Formulations in Healthy Volunteerstreatment1completed
NCT05090631
The Role of Genetic Factors in the Development of Atopic Dermatitis in the Kazakh PopulationNo drug interventionsNot AvailableNot Availablecompleted
NCT04334031
Deployment o the Multidisciplinary Prospective Cohort ImminentNo drug interventionsotherNot Availablerecruiting
NCT04018131
The Efficacy of Cimetidin for Acute - Extrinsic Atopic Dermatitis Treated With Standard Therapytreatment3unknown_status
NCT02595073
Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic DermatitisNo drug interventionstreatment3completed
NCT03269773
Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderate to Severe Chronic Atopic Dermatitis(AD)No drug interventionstreatment3completed
NCT00325273
Prevention Allergic Disease of Infant With Probiotics During Pregnancy and Neonatal PeriodNo drug interventionsprevention3completed
NCT00660127
The Effect of Visual Stimuli on Itch Perception Intensity in Healthy and Atopic Dermatitis PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT04018027
Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitistreatment2completed
NCT05994976
Collection of Samples From Subjects With Various Skin Conditions and Healthy VolunteersNo drug interventionsNot AvailableNot Availablerecruiting
NCT03796676
JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitistreatment3completed
NCT03112876
Sebum Collection and Skin Barrier Function AnalysisNo drug interventionsNot AvailableNot Availablecompleted
NCT05682976
Ophthalmological Adverse Events of Tralokinumab in ADNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06504160
Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)treatment2not_yet_recruiting
NCT03540160
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)treatment3terminated
NCT03485560
Revitalization of Damaged Skin Due to Chronic Skin DiseasesNo drug interventionstreatment0unknown_status
NCT01475994
Effect of Pollen Challenges on Dermal Symptoms in Patients With Atopic DermatitisNo drug interventionsbasic_scienceNot Availablecompleted
NCT04605094
Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic Dermatitistreatment2terminated
NCT03542994
A Study of EDP1066 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic DermatitisNo drug interventionstreatment1completed
NCT00985894
Comparison Between Asynchronous Online Care Model With Usual In Office Care for the Management of Atopic DermatitisNo drug interventionshealth_services_researchNot Availablecompleted
NCT06009094
Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients With Mild to Moderate Atopic DermatitisNo drug interventionstreatment1completed
NCT03050294
Evaluating Treatment Resistant Dermatitis TaroIIRtreatment4completed
NCT02525094
Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitistreatment2completed
NCT01936194
The Effects of Polyunsaturated Fatty Acids (PUFA) on Allergic/Atopic DermatitisNo drug interventionsNot AvailableNot Availablewithdrawn
NCT02910791
The Role of Bacterial Toxins in Human Skin DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT02073591
Correlation Study Between PEST and SCORAD in Management of Atopic Dermatitis With Ceradan® RegimenNo drug interventionsNot AvailableNot Availablecompleted
NCT06026891
Study of MG-K10 Humanized Monoclonal Antibody Injection in Patients With Atopic DermatitisNo drug interventionstreatment3recruiting
NCT03018691
Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitistreatment2completed
NCT05644691
Impact of the Daily Use of Emollient on Corticosteroids Consumption in Patients With Atopic DermatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT01522391
A Randomized, Double-blinded Placebo-controlled Study to Investigate Antimicrobial Efficacy and Safety Following Topical Application of DPK-060No drug interventionstreatment1 / 2completed
NCT01467362
Efficacy Emollient on Xerosis in Children With Atopic Dermatitistreatment3completed
NCT05598762
The Transcriptomic Study of Thai Patients With Atopic Dermatitis by Tape StripsNo drug interventionsbasic_scienceNot Availablenot_yet_recruiting
NCT04021862
A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitistreatment2completed
NCT00810862
Study of Pimecrolimus Treatment for Atopic Dermatitis of African American Childrentreatment4terminated
NCT06092762
A Phase II Study to Evaluate the Safety and Efficacy of AK120 in Subjects With Moderate to Severe Atopic DermatitisNo drug interventionstreatment2not_yet_recruiting
NCT04307862
Safety, Tolerability and Efficacy of ZEP-3Na (0.1% or 1%) Compared to Placebo in Subjects With Mild to Moderate Atopic DermatitisNo drug interventionstreatment2recruiting
NCT05566262
Bodewell Products for the Treatment of Atopic DermatitisNo drug interventionstreatment4recruiting
NCT04612062
A First-in-Human Study of CEE321 in Adult SubjectsNo drug interventionstreatment1completed
NCT05507580
A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitistreatment4completed
NCT02210780
Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD)treatment2completed
NCT05121480
A Study Investigating the Effect of EDP1815 in the Treatment of Mild, Moderate and Severe Atopic Dermatitistreatment2completed
NCT01179880
A Study of E6005 in Japanese Patients With Atopic Dermatitistreatment1 / 2completed
NCT04839380
The Purpose of the Study is to Evaluate the Effect of Ruxolitinib Cream on Itch in Participants With Atopic Dermatitistreatment2completed
NCT05833880
Use of Complementary and Alternative Medicine in Children and Adults With Atopic DermatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT06495229
Study of CM310 in Adolescent Subjects With Atopic Dermatistreatment3not_yet_recruiting
NCT00376129
Open-Label,Singel Center Study of Alefacept in Patients With Atopic Dermatitisdiagnostic2completed
NCT06362629
AI App for Management of Atopic DermatitisNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT04090229
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic DermatitisNo drug interventionstreatment1completed
NCT02757729
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Adults With Atopic Dermatitistreatment2completed
NCT01179529
Atopic Dermatitis Biomarker Identification Trial in Omalizumab Usagetreatment2completed
NCT06119529
A Study of LY3872386 in Healthy Participants and Participants With Atopic Dermatitisbasic_science1terminated
NCT00455429
An Efficacy and Safety Study of JNJ-26113100 in the Treatment of Adult Atopic DermatitisNo drug interventionstreatment2terminated
NCT02289989
Oregano Ointment vs. Standard Treatment for Pediatric Atopic DermatitistreatmentNot Availableterminated
NCT01678092
Single Center Study Using Omalizumab in Subjects With Atopic Dermatitistreatment1completed
NCT06005792
Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic DermatitisNo drug interventionstreatment1active_not_recruiting
NCT05696392
The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.treatment4recruiting
NCT06361992
Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in ChildrenNo drug interventionstreatment3completed
NCT00310492
Efficacy and Safety Trial of ALK-depot SQ Mites in Subjects With Atopic DermatitisNo drug interventionstreatment3completed
NCT04226092
Pre-SunBeam TEWL AUCNo drug interventionsotherNot Availablecompleted
NCT03100344
Dose-ranging Study of Nemolizumab in Atopic Dermatitistreatment2completed
NCT03257644
A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitistreatment1completed
NCT04826744
Frequency of Palpebral Involvement in Adult With Atopic DermatitisNo drug interventionsNot AvailableNot Availablerecruiting
NCT02148744
Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic DermatitisNo drug interventionstreatment1completed
NCT00879944
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass IndexNo drug interventionsNot AvailableNot Availablecompleted
NCT04170244
Study of Skin Microbiome in AD and PS PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT01639040
Study to Assess the Safety of Dupilumab (REGN668/SAR231893) Administered Concomitantly With Topical Corticosteroids (TCS) in Patients With Moderate-to-severe Atopic Dermatitis (AD)treatment2completed
NCT05194540
Efficacy and Safety of Tralokinumab Administered by an Autoinjector in Adults and Adolescents With Moderate to Severe Atopic Dermatitis (INJECZTRA)treatment3completed
NCT06136767
Registry for Systemic Eczema TreatmentsNo drug interventionsNot AvailableNot Availablerecruiting
NCT04345367
Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapytreatment3completed
NCT04033367
SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"treatment4completed
NCT00392067
LEO19123 Cream in the Treatment of Atopic Dermatitistreatment2completed
NCT04178967
Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitistreatment3completed
NCT02780167
Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitistreatment2completed
NCT03539601
A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate ADtreatment4terminated
NCT03800004
Bone Health in Patients With Atopic DermatitisNo drug interventionsNot AvailableNot Availablerecruiting
NCT05363904
Atopic Dermatitis: Sub-Saharan Africa vs. Central EuropeNo drug interventionsNot AvailableNot Availablerecruiting
NCT06547372
Dietary Intervention on AtopyNo drug interventionstreatmentNot Availablerecruiting
NCT01992172
Photocil (Topical) for the Treatment of Atopic DermatitistreatmentNot Availablecompleted
NCT02103972
Assessment of Efficacy of the Consumption of a Heat-treated Lactobacillus Paracasei (GM080) on Atopic DermatitisNo drug interventionstreatmentNot Availablecompleted
NCT03813472
Hydration Sensor for Atopic DermatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT05326672
Phase III Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Atopic Dermatitistreatment3unknown_status
NCT00809172
Study of Methotrexate Efficacy Versus Cyclosporine in Moderate to Severe Atopic Dermatitis Patientstreatment3completed
NCT02324972
Pilot Efficacy and Safety Study of AQX-1125 in Atopic Dermatitistreatment2completed
NCT04927572
Safety, Pharmacokinetics and Efficacy of FMX114 Versus Vehicle in Adults With Atopic DermatitisNo drug interventionstreatment1 / 2completed
NCT04283968
Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic DermatitisNo drug interventionstreatment3unknown_status
NCT00177268
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis ResearchNo drug interventionsNot AvailableNot Availablerecruiting
NCT05399368
An Efficacy and Safety Study of RPT193 in Adults With Atopic DermatitisNo drug interventionstreatment2terminated
NCT03441568
In-home Use Test of the New Modified Diprobase Formulation to Assess the Safety and Tolerability in Infants and Children Under Physician's ControlNo drug interventionstreatmentNot Availablecompleted
NCT04976868
Observational Study to Evaluate the Actual Use of Elidel® in Chinese Patients With Mild to Moderate Atopic DermatitisNot AvailableNot Availablecompleted
NCT00407069
Role of Antimicrobial Peptides in Host Defense Against Vaccinia VirusNo drug interventionsNot AvailableNot Availablecompleted
NCT04212169
Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitistreatment2completed
NCT04598269
Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic DermatitisNo drug interventionstreatment2completed
NCT01093469
Comparing Aquaphor to Atopiclair and EpiCeram in Children With Mild to Moderate Atopic Dermatitistreatment4completed
NCT04921969
A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)treatment3completed
NCT00717769
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic DermatitisNo drug interventionstreatment2completed
NCT06259669
Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control PopulationNot AvailableNot Availablerecruiting
NCT02365246
Treatment of AD With IgE Specific Immunoadsorption (IGEIAAD)No drug interventionstreatment2recruiting
NCT03402412
Atopic Dermatitis: Early Gene Expression Changes as Predictors of Therapeutic Response to Narrow-band UVB TreatmentNo drug interventionsbasic_scienceNot Availableunknown_status
NCT05624112
Dupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in Chinatreatment4completed
NCT03431610
A Phase 1b Study Assessing the PK, PD, Safety & Tolerability of SB414 in Atopic DermatitisNo drug interventionstreatment1completed
NCT01326910
Human Testing of an Over-the-Counter (OTC) Cream in Children With EczemaNo drug interventionstreatmentNot Availablecompleted
NCT00697710
A Phase Ib/IIa, Double-Blind, Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of S-777469 in Subjects With Atopic Dermatitistreatment1 / 2completed
NCT05945810
Evaluation of TLL-018 Extended and Immediate Release Formulation for Bioequivalence Testing in Healthy Chinese SubjectsNo drug interventionstreatment1completed
NCT06319781
A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or VitiligoNo drug interventionsNot AvailableNot Availablerecruiting
NCT01702181
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitistreatment1completed
NCT06214481
A Study to Evaluate Rocatinlimab (AMG 451) in Healthy Chinese Participantsbasic_science1completed
NCT02716181
Efficacy of the "Атопик Soothing Cream" in Children With Mild to Moderate Atopic DermatitisNo drug interventionstreatmentNot Availablecompleted
NCT02889081
Maternal Key Nutritional Factors and Offspring's Atopic Dermatitis (MKNFOAD)No drug interventionsNot AvailableNot Availablecompleted
NCT02125695
Pilot Tape Harvesting StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00557895
Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory DisordersNo drug interventionsNot AvailableNot Availableterminated
NCT05029895
A Study to Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD)No drug interventionsNot AvailableNot Availablerecruiting
NCT00533195
Comparison of UVA1 Phototherapy Versus Photochemotherapy for Patients With Severe Generalized Atopic Dermatitistreatment3completed
NCT04699695
A Prospective Sample Collection Study Using Non-invasive Methods to Investigate Biomarkers in AD PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT04140695
Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2)treatment3terminated
NCT03667014
The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis Patientstreatment4completed
NCT02651714
Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitistreatment2completed
NCT05470114
A Multi-omics Disease Signature Trial in Adult Patients With Moderate to Severe ADtreatment2completed
NCT06309355
Topical YR001 Ointment in Adult With Mild to Moderate Atopic DermatitisNo drug interventionstreatment2recruiting
NCT05253755
Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous GelNo drug interventionstreatment2terminated
NCT05633355
A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)treatment3active_not_recruiting
NCT05971355
Comparison of LimpiAD Cream 2.5% Plus Versus Vehicle and an Emollient in Patients With Atopic DermatitisNo drug interventionstreatmentNot Availablerecruiting
NCT01139450
Study of 0417 Ointment in the Treatment of Atopic Dermatitistreatment3completed
NCT02224950
Study to Examine the Benefits of Fabric Made With Lyocell/Chitosan/Ceramide in the Treatment of Children With Mild to Moderate EczemaNo drug interventionstreatmentNot Availablewithdrawn
NCT05517850
Therapist-guided vs Self-guided CBT for AD: Non-inferiority TrialNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00098150
Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic DermatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT01996150
Bleach Bath Treatment of Adults With Atopic DermatitistreatmentNot Availablecompleted
NCT05276323
Medihoney® Derma Cream Treatment for Mild to Moderate Atopic Dermatitis in Children Studytreatment2completed
NCT06082323
A Single and Multiple Ascending Dose Trial of LT-002-158 in Healthy Adult VolunteersNo drug interventionstreatment1not_yet_recruiting
NCT06101823
Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe Atopic DermatitisNo drug interventionstreatment2active_not_recruiting
NCT04276623
Identifying Atopic Dermatitis Patients at Risk for Developing Conjunctivitis During Dupilumab TreatmentNo drug interventionsNot AvailableNot Availablerecruiting
NCT03738423
Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitistreatment2terminated
NCT01996423
Impact of Vitamin D Supplementation on Severity of Pediatric Atopic DermatitisNo drug interventionstreatmentNot Availablecompleted
NCT05158023
Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic DermatitisNo drug interventionstreatment2completed
NCT04520308
An Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic Dermatitisdiagnostic4unknown_status
NCT05215808
SAD/MAD Safety and PK Study of RBN-3143 in Healthy and Atopic Dermatitis SubjectsNo drug interventionstreatment1recruiting
NCT02791308
Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitistreatment3completed
NCT05642208
Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitistreatment4recruiting
NCT02176538
Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric SubjectsNo drug interventionstreatment3withdrawn
NCT03661138
A Study to Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitistreatment3completed
NCT04818138
BROadband vs Narrowband photoTherapy for Eczema Trial Nested in the CACTI CohortNo drug interventionstreatmentNot Availablerecruiting
NCT00616538
Epiceram™ Device Versus Mid-Strength Topical Steroid (Fluticasone Propionate 0.05%) for Treatment of Atopic Dermatitistreatment4completed
NCT05571943
A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitistreatment3completed
NCT04530643
A Phase II Study of HY209 Gel for Atopic Dermatitis Patients (Shaperon)No drug interventionstreatment2completed
NCT05170243
A Clinical Study in Healthy Subjects to Evaluate 9MW1911 InjectionNo drug interventionstreatment1completed
NCT05288543
A Study of Orally Administered IPG7236 in Healthy Adult ParticipantsNo drug interventionstreatment1unknown_status
NCT03684343
Comparative Analysis of Filmed Sequences for the Assessment of Discomfort in Atopic Dermatitis of Infants Under 6 Months of AgeNo drug interventionsotherNot Availableterminated
NCT01049243
A Study Evaluating the Efficacy of Fluocinonide Cream 0.1% (Vanos) in Subjects With Atopic Dermatitistreatment4completed
NCT06175143
A Study to Evaluate the Safety and Efficacy of GR2002 Injection in Patients With Atopic Dermatitis.No drug interventionstreatment1not_yet_recruiting
NCT05200403
Improvement In Scratch Behavior And Sleep In Patients With Atopic Dermatitistreatment4terminated
NCT02601703
To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)treatment3completed
NCT01782703
Defining the Skin and Blood Biomarkers of Pediatric Atopic DermatitisNo drug interventionsNot AvailableNot Availablerecruiting
NCT01230190
Management of Eczema by Specific Probiotic StrainsNo drug interventionstreatment3withdrawn
NCT03817190
Efficacy and Safety of Orally Administered DS107 in Adult Patients With Moderate to Severe Atopic DermatitisNo drug interventionstreatment2terminated
NCT00509990
Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Settingtreatment4completed
NCT01074164
Acupressure in Pruritus for Atopic DermatitisNo drug interventionstreatmentNot Availablecompleted
NCT05995964
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic DermatitisNo drug interventionstreatment2recruiting
NCT05469464
Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS)treatment2active_not_recruiting
NCT00130364
Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitistreatment4completed
NCT05127421
Ruxolitinib Cream in Participants With Facial and/or Neck Atopic Dermatitis Involvementtreatment2completed
NCT04239521
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia AreataNo drug interventionsNot AvailableNot Availablecompleted
NCT03614221
Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic Dermatitistreatment2completed
NCT04922021
An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.No drug interventionstreatment2completed
NCT00806221
An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitisprevention2completed
NCT04325802
Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexonetreatment2withdrawn
NCT06492902
Adding Auricular Acupuncture to Xiao-Feng-San Decoction for Treating Atopic DermatitisNo drug interventionstreatmentNot Availablerecruiting
NCT00316602
A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitisprevention2completed
NCT03703102
Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitistreatment2completed
NCT00120302
Quality of Life Study in Adults With Facial Eczematreatment4completed
NCT06448702
Evaluation of Efficacy and Safety of Enhanced External Counter-pulsation on Patients With Atopic Dermatitis and Inflammatory Skin Disease Requiring Wet Wrap TherapyNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT04023084
Response of Children With Atopic Dermatitis (Eczema) to Eucrisaother4completed
NCT05016284
Comparison of JW-100 and EUCRISA for the Treatment of Atopic Dermatitistreatment3withdrawn
NCT04504279
Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic DermatitisNo drug interventionstreatment2completed
NCT02871479
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic DermatitisNo drug interventionstreatment2completed
NCT00833079
Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Atopic Dermatitistreatment1completed
NCT00407979
Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and PsoriasisNo drug interventionsNot AvailableNot Availablecompleted
NCT01320579
Investigation of the Efficacy of 2.5% and 5% Cis-urocanic Acid in Patients With Moderate or Severe Atopic Dermatitistreatment2completed
NCT03397979
Twice Daily Versus Twice Weekly Soak-and-Seal Baths in Pediatric Atopic DermatitisNo drug interventionstreatmentNot Availablecompleted
NCT01359787
Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD)treatment2completed
NCT04360187
Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic Dermatitistreatment3completed
NCT06553287
Safety, Tolerability and Pharmacokinetics of LNK01004 Ointment in Adults With Atopic Dermatitis.No drug interventionstreatment1completed
NCT00886587
To Evaluate the Safety and Efficacy of a New Device in the Management of Mild to Moderate Atopic Dermatitis in ChildrenNo drug interventionsbasic_scienceNot Availablecompleted
NCT05437887
Effects of Fucoidan on the Gut Microbiota in the Patients of Atopic DermatitisNo drug interventionstreatmentNot Availablerecruiting
NCT04715087
Staphylococcus Aureus in Atopic Dermatitis ImmunopathologyNo drug interventionsbasic_scienceNot Availablerecruiting
NCT02219633
Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)No drug interventionstreatment1completed
NCT01986933
A Phase 2 Study of CIM331 for Atopic Dermatitis Patientstreatment2completed
NCT04476433
Intervention in Chronic Pediatric Patients and Their Families.No drug interventionspreventionNot Availablecompleted
NCT04154033
Treatment of Chronic Itch in Atopic Dermatitis With Topical Naltrexonetreatment2withdrawn
NCT02395133
A Study to Confirm the Efficacy and Safety of Different Dupilumab Dose Regimens in Adults With Atopic Dermatitis (AD)treatment3completed
NCT06313333
National Register of Moderate and Severe Adult Atopic DermatitisNo drug interventionsNot AvailableNot Availablerecruiting
NCT05905133
A Study to Evaluate the Safety and Efficacy of CBP-201 in Chinese Adult Subjects With Moderate to Severe ADtreatment2active_not_recruiting
NCT01231854
Ciclosporin Versus Alitretinoin for Severe Atopic Hand Dermatitis.treatment4terminated
NCT00200954
Primary Prevention of Atopic Disease by Perinatal Administration of ProbioticsNo drug interventionspreventionNot Availablecompleted
NCT06035354
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of AK120 in Subjects With Atopic DermatitisNo drug interventionstreatment1 / 2recruiting
NCT02612454
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)treatment3active_not_recruiting
NCT05031754
Assessing SleeP IN Infants With Atopic Dermatitis by Longitudinal EvaluationNo drug interventionsNot AvailableNot Availableunknown_status
NCT03533751
Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic Dermatitistreatment2completed
NCT05689151
A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.Not AvailableNot Availablerecruiting
NCT01132651
Cooling Pillow for Atopic DermatitisNo drug interventionssupportive_careNot Availablecompleted
NCT04325451
Comprehending Atopic Risk ElementsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04174651
Stress-induced Scratching in Healthy and ADNo drug interventionsbasic_scienceNot Availablecompleted
NCT03745651
TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitistreatment3completed
NCT06578351
TRacking Atopic Dermatitis Infants and Their Microbiome (TRAM)No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02424253
A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Atopic DermatitisNo drug interventionstreatment2completed
NCT04587453
Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic Dermatitistreatment3completed
NCT03733353
A Study of EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitistreatment1completed
NCT03394677
Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic DermatitisNo drug interventionstreatment2completed
NCT04218877
The Factors Affecting Atopic Dermatitis in Children Age 1-3No drug interventionsNot AvailableNot Availablecompleted
NCT03356977
A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitistreatment4completed
NCT05466877
A Study of MG-K10 in Subjects With Atopic DermatitisNo drug interventionstreatment2active_not_recruiting
NCT05131477
Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD Studytreatment2completed
NCT05491447
A Clinical Trial of BMX-010 in Adult Subjects With Atopic DermatitisNo drug interventionstreatment2terminated
NCT03051347
Asthma and Atopic Dermatitis Validation of PROMIS Pediatric InstrumentsNo drug interventionsotherNot Availablecompleted
NCT06268847
Efficacy of Marine By-product Hydrolysate on the Reduction of Atopic Dermatitis SymptomsNo drug interventionssupportive_careNot Availablecompleted
NCT03581747
Detection of Skin Epithelial Barrier in Patients With Allergic Skin DisordersNo drug interventionsNot AvailableNot Availableunknown_status
NCT01714245
A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT06277245
A Phase 3 Study of LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis.No drug interventionstreatment3recruiting
NCT06194045
Nutritional Study to Determine the Effect of Fish Oil on Atopic DermatitisNo drug interventionspreventionNot Availablerecruiting
NCT00882245
Safety and Efficacy of SRD441 Ointment in Patients With Atopic DermatitisNo drug interventionstreatment2completed
NCT05398445
A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)treatment3active_not_recruiting
NCT03492398
A Phase I Study of HY209 Gel in Healthy Male Volunteers for Atopic DermatitisNo drug interventionstreatment1completed
NCT00173498
Common Allergens in Skin Tests for Adult Atopic DermatitisNo drug interventionsNot AvailableNot Availableunknown_status
NCT02908698
Effect of Oral Steroids on Skin Outcomes in Atopic Dermatitisbasic_scienceNot Availableterminated
NCT00231998
Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic Dermatitistreatment3completed
NCT04066998
Cytokine Profile of Conjunctivitis, Performed Through Tears Analysis Among Patients Treated With DupilumabNo drug interventionsotherNot Availableunknown_status
NCT02594098
Secukinumab for Treatment of Atopic Dermatitistreatment2completed
NCT05680298
Dupilumab-pediatric Skin Barrier Function and Lipidomics Study in Patients With Atopic Dermatitis in Chinatreatment4completed
NCT05378698
Effects of Tralokinumab in the Skin: an Immunologic and Molecular Investigationbasic_science2 / 3not_yet_recruiting
NCT02864498
Efficacy and Safety Study of Orally Administered DS107 in Moderate to Severe Atopic Dermatitis PatientsNo drug interventionstreatment2completed
NCT01375205
Comparing Cetaphil Restoraderm System Versus Standard Skin Care in InfantsNo drug interventionsotherNot Availablecompleted
NCT01689805
Clinical Importance of Filaggrin Gene Mutation for Treatment Outcome in Atopic DermatitisNo drug interventionsNot AvailableNot Availableunknown_status
NCT00863005
Assessment of the Effects on Barrier Impairment, Clinical Features and Bacterial Colonization of Topical Formulations in Patients With Atopic Eczema; a Phase IIa, Single-center, Randomized, Observer-blind StudyNo drug interventionsNot Available1 / 2completed
NCT00753805
Dietetic Effects of Mare's Milk in Patients With Atopic DermatitisNo drug interventionstreatmentNot Availablecompleted
NCT03738397
A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitistreatment3completed
NCT00568997
10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used PimecrolimusNot AvailableNot Availablerecruiting
NCT04626297
A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)treatment3completed
NCT04114097
The Effects of Topical Corticosteroid Use on Insulin Sensitivity and Bone Turnoverother4completed
NCT05735483
A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitistreatment3enrolling_by_invitation
NCT00822783
Study to Determine the Effect of an Anti-IgE Agent on Inflammatory Cells in the Skin of Atopic Dermatitis PatientsNot Available4completed
NCT03058783
Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult SubjectsNo drug interventionstreatment3completed
NCT05790083
Skin Efficacy and Tolerability of a Cosmetic Product Combination Over 3 Months in Subjects With Atopic EczemaNo drug interventionsotherNot Availableactive_not_recruiting
NCT06516783
Blue Light in the Treatment of Inflammatory Skin DiseasesNo drug interventionstreatmentNot Availablecompleted
NCT05765461
Effect of Lipikar Baume AP+M on Quality of Life and Pain of Adults With Dryness or Severe XerosisNo drug interventionsNot AvailableNot Availablecompleted
NCT01826461
An Evaluation of PDI-192 0.1% in Comparison to PDI-192 0.15% in the Treatment of Mild to Moderate Atopic DermatitisNo drug interventionstreatment2completed
NCT03526861
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).treatment3completed
NCT06055361
A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic DermatitisNo drug interventionstreatment1recruiting
NCT04750161
The Role Of Neutrophil Proteases As Global Regulators Of Il-1 Family Cytokine Activity In Skin DisordersNo drug interventionsNot AvailableNot Availableunknown_status
NCT02345928
A Single Ascending Dose Study in Healthy Participants and Multiple Ascending Dose Study of CNTO 7160 in Participants With Asthma and Participants With Atopic Dermatitistreatment1completed
NCT06474728
Effects of an Emollient Containing Postbiotic Saccharomyces and Lactobacillus on Pediatric Atopic DermatitisNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT02683928
To Assess the Safety and Activity of GBR 830, Compared to Placebo, in Adults With Moderate-to-severe Atopic Dermatitistreatment2completed
NCT01949311
Open-label Study of Dupilumab in Patients With Atopic Dermatitistreatment3completed
NCT05656911
A Study to Learn How Well the Study Treatment Zabedosertib (BAY1834845) Works and How Safe it is Compared to Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitistreatment2completed
NCT05651711
A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)treatment3completed
NCT04468711
Vitamin D in Egyptian Children With Atopic Dermatitistreatment3completed
NCT01174511
Evaluation of A-1 Cool Cream Efficacy for Treatment Atopic DermatitisNo drug interventionssupportive_care1 / 2unknown_status
NCT03107611
Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic Dermatitistreatment3completed
NCT02920411
Effectiveness of a Combined Dermatological Treatment in Children With Atopic DermatitisNo drug interventionstreatmentNot Availablecompleted
NCT03514511
Safety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic DermatitisNo drug interventionstreatment1completed
NCT01429311
Interferon Responses in Eczema HerpeticumNo drug interventionsNot AvailableNot Availablecompleted
NCT03569293
Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)treatment3active_not_recruiting
NCT03358693
Molecular Signatures in Inflammatory Skin DiseaseNot AvailableNot Availablerecruiting
NCT05137093
Scratching Validation StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT01489293
Inhibitory Receptors in Eosinophils of Atopic SubjectsNo drug interventionsNot AvailableNot Availablecompleted
NCT03568071
A Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics (PK)/Pharmacodynamics (PD) of MOR106 in Subjects With Moderate to Severe Atopic DermatitisNo drug interventionstreatment2terminated
NCT06390878
Nationwide Research on the Rewilding of Kindergarten YardsNo drug interventionspreventionNot Availablerecruiting
NCT00379678
Effects of Pimecrolimus on Skin Biopsy Ex-plants From Patients With Atopic DermatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT05938478
Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECTNot AvailableNot Availablerecruiting
NCT01518478
Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Pilotbasic_science0completed
NCT02669888
Indigo Naturalis in Treating Atopic Dermatitis Topicallytreatment2completed
NCT06213688
Involvement of Pollutants in Atopic Dermatitis and PsoriasisNo drug interventionsbasic_scienceNot Availablenot_yet_recruiting
NCT02926807
Trial on Vascular Inflammation in Atopic DermatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT01695707
Assessing the Impact of Pioglitazone on Skin Barrier Function in Atopic Dermatitis PatientstreatmentNot Availablewithdrawn
NCT06162507
Study of CM310 in Children Subjects With Moderate-to-severe Atopic Dermatistreatment1 / 2not_yet_recruiting
NCT05268107
Ethnic Differences in Mechanisms of Action of Dupilumabbasic_science4recruiting
NCT05387707
Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitistreatment3terminated
NCT04271007
Comparative Study:Topison (Mometasone Furoate) Versus Two Others Mometasone Furoatesother4completed
NCT01234909
Asthma, Missed Immunizations, and Vitamin D Deficiency in Atopic DermatitisNo drug interventionsNot AvailableNot Availableterminated
NCT02537509
PRAgmatic Trial in Atopic Dermatitis Testing Long-term Control Effectiveness of New Phototherapy Regimen During Winter Coupled With Oral Vitamin D Supplementation vs. Placebotreatment2completed
NCT04490109
B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic DermatitisNo drug interventionstreatment2completed
NCT06316609
Prenatal Exposure to Emerging Contaminants and Children's Atopic DermatitisNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01423656
Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102No drug interventionsNot Available1completed
NCT02407756
A Study to Determine the Safety and Tolerability of Dupilumab (REGN668/SAR231893) in Patients Aged ≥6 to <18 Years With Atopic Dermatitis (Eczema)treatment2completed
NCT02865356
Topical Solution for the Treatment of Atopic Dermatitistreatment2completed
NCT03245385
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitistreatment2terminated
NCT05502185
Targeting Staphylococci in Atopic DermatitisNo drug interventionsNot AvailableNot Availableunknown_status
NCT00832585
Study to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic Dermatitistreatment4completed
NCT04800185
Characterizing Skin Microbiome Change in Atopic Dermatitishealth_services_research0completed
NCT03361215
Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and PsoriasisNo drug interventionsNot AvailableNot Availablerecruiting
NCT02178215
Effect of Holly Mangrove Shower Gel in Atopic Dermatitis PatientsNo drug interventionstreatment3completed
NCT04606615
Skin Barrier Abnormalities and Oxidative Stress ResponseNo drug interventionsNot AvailableNot Availableunknown_status
NCT04211415
Phase I Study of DS-2741a in Healthy Volunteers and Participants With Atopic DermatitisNo drug interventionstreatment1terminated
NCT01941537
Randomized Placebo Controlled Study to Determine Safety, Pharmacodynamics and Efficacy of ILV-094 in Atopic Dermatitistreatment2completed
NCT03761537
Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis - ECZTRA 7treatment3completed
NCT03411837
Dupilumab Phase 4 StudyNot AvailableNot Availableterminated
NCT02091037
S. Aureus Colonization in Atopic DermatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT03843437
Tencel vs. Standard Cotton Therapeutic Garments as an Adjunct Treatment for Moderate to Severe Atopic Dermatitis in ChildrenNo drug interventionstreatmentNot Availablewithdrawn
NCT04613037
Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic DermatitisNo drug interventionstreatment0completed
NCT04250337
Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis.treatment3completed
NCT05989932
Real-world Experience on the Use of Upadacitinib in the Treatment of Moderate-severe Adult Atopic Dermatitis (ERUDA)No drug interventionsNot AvailableNot Availablerecruiting
NCT00224432
Double-Blind, Parallel, Randomised Study to Investigate the Effect of Oral Probiotics in Infants With Atopic DermatitistreatmentNot Availablecompleted
NCT01137032
Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult Populationtreatment4completed
NCT02369432
Exploratory Study of the Cutaneous Penetration of Biodegradable Polymeric Microparticles in Atopic DermatitisNo drug interventionsother0terminated
NCT02795832
A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitistreatment1 / 2completed
NCT06366932
Optimization of Atopic Dermatitis Treatment That Requires Second-line Systemic Therapy Through Predictive Modelstreatment4recruiting
NCT00351052
Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitistreatment3completed
NCT00167752
Psychiatric Problems in Chronic Skin DiseasesNo drug interventionsNot AvailableNot Availablecompleted
NCT03920852
A Maximum Use Trial of Ruxolitinib Cream in Adolescent and Adult Participants With Atopic Dermatitistreatment1completed
NCT02116452
Prebiotics in Prevention of AtopyNo drug interventionsprevention3completed
NCT04313400
Topically Applied AMTX-100 CF for Adult Patients With Mild to Moderate Atopic DermatitisNo drug interventionstreatment1 / 2completed
NCT05006300
Evaluation of the Efficacy of Topialyse Baume barrière on Atopic DermatisNo drug interventionstreatmentNot Availablewithdrawn
NCT06487000
To Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate or Severe Atopic Dermatitistreatment2not_yet_recruiting
NCT00378300
The Effects of Probiotics in Atopic DermatitisNo drug interventionstreatmentNot Availablewithdrawn
NCT00546000
Cutivate Lotion HPA Axis Pediatric Studytreatment4completed
NCT04681300
Transcriptomic Landscape of T Lymphocytes of Atopic Dermatitis, Atopic Prurigo Nodularis (of Besnier) and Non-atopic Prurigo Nodularis (of Hyde) Using Single Cell RNA-sequencingNo drug interventionsNot AvailableNot Availableunknown_status
NCT06058000
A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic DermatitisNo drug interventionstreatment2not_yet_recruiting
NCT05662800
Development of Peanut, Sesame, and Tree Nut Allergy in Polish Children at High Risk of Food AllergyNo drug interventionsNot AvailableNot Availablerecruiting
NCT03952559
A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitistreatment3active_not_recruiting
NCT00150059
Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic Dermatitistreatment4completed
NCT01216059
Text Messaging and Atopic DermatitisNo drug interventionstreatmentNot Availablecompleted
NCT03912259
Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitistreatment3completed
NCT04404075
Skin Tracker: A Mobile Health App to Monitor Skin Disease Activity and Treatment UseNo drug interventionsNot AvailableNot Availablecompleted
NCT03018275
Beginning Assessment of Cutaneous Treatment Efficacy of Roseomonas in Atopic DermatitisNo drug interventionstreatment1 / 2completed
NCT00878670
Investigation of Efficacy and Safety of EPOGAMtreatment4completed
NCT03908970
Comparison Trial of OPA-15406 Ointment in Adult Patients With Atopic DermatitisSyndrometreatment3completed
NCT04352270
Clinic-Based Atopic Dermatitis Therapeutic Patient EducationNo drug interventionshealth_services_researchNot Availablecompleted
NCT03559270
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitistreatment3terminated
NCT03719742
A Clinical Study to Evaluate the Safety and Efficacy of a Baby Cleanser and a MoisturizerNo drug interventionssupportive_careNot Availablecompleted
NCT00757042
Safety Study of Tezepelumab (AMG 157) in Healthy Adults and Adults With Atopic Dermatitistreatment1completed
NCT00610142
Comparison of Atrophogenic Effect of Hydrocortison 1% Cream and Pimecrolimus 1% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHz Ultrasound of Uninvolved Skin in Patients With Atopic Dermatitistreatment2completed
NCT00931242
Study of Apremilast in Atopic or Contact Dermatitistreatment2completed
NCT05676242
A Phase III Extended Clinical Trial of Jaktinib Hydrochloride Tablets in the Treatment of Moderate and Severe Atopic Dermatitistreatment3recruiting
NCT06024499
Phase 2 Trial of HY209gel in Atopic Dermatitis PatientsNo drug interventionstreatment2recruiting
NCT03761199
Assessment of the Impact of Whole Body Cryostimulation on Skin Physiological IndicatorsNo drug interventionsbasic_scienceNot Availablecompleted
NCT04455906
Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 PolymorphismNo drug interventionsNot AvailableNot Availablerecruiting
NCT01016106
Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American PopulationNo drug interventionsdiagnosticNot Availablecompleted
NCT00419406
Medium-Dose UVA1 Versus Narrow-Band UVB in Atopic DermatitisNo drug interventionstreatmentNot Availablecompleted
NCT02975206
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitistreatment2completed
NCT05719649
The Efficacy of NTU 101 Lactic Acid Bacteria Powder in the Adjuvant Improvement of Atopic Dermatitis Clinical TrialNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT06129136
The Effect of Nature-based Exposure on the Immune System and Skin Health of Atopic Dermatitis Patients.No drug interventionsbasic_scienceNot Availableactive_not_recruiting
NCT02677636
Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and OlderNo drug interventionstreatment3withdrawn
NCT01228513
Efficacy and Safety of Different Concentrations of ZK245186 in Atopic Dermatitis (AD)treatment2completed
NCT06073613
Periodontal Status in Patients With Chronic Skin DiseasesNo drug interventionsNot AvailableNot Availablecompleted
NCT01124318
A Pilot Study of Lactofiltrum to Treat Atopic Dermatitis in Adultstreatment2 / 3completed
NCT03863418
Probiotic Lactobacillus Rhamnosus GG for Pediatric Atopic DermatitisNo drug interventionstreatmentNot Availableunknown_status
NCT03568318
A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitistreatment3enrolling_by_invitation
NCT01471119
Sublingual Immunotherapy in Patients With Atopic DermatitisNo drug interventionstreatment2completed
NCT05372419
A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Colortreatment3active_not_recruiting
NCT02004119
Phase 2 Study of KHK4577No drug interventionstreatment2completed
NCT05858619
Molecular Signatures of Cutaneous Dupilumab Responsebasic_science4recruiting
NCT00180141
Elidel-Study: Elidel in Patients With Atopic Dermatitistreatment4completed
NCT02102841
Investigating Immune Mechanisms in Atopic Eczemabasic_scienceNot Availablewithdrawn
NCT05911841
A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic DermatitisNo drug interventionstreatment2recruiting
NCT05084417
A Prospective, Observational Study of Clinician and Patient-reported Outcomes in Patients With Dermatological ConditionsNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT03406117
A Study to Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch TestsNo drug interventionsbasic_science4completed
NCT05614817
CBP-201 in Adolescent and Adult Patients With Moderate-to-severe Atopic Dermatitistreatment3withdrawn
NCT01597817
Efficacy and Safety of a a Biofunctional Textile in the Management of Atopic DermatitisNo drug interventionstreatment2completed
NCT05265234
Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging.treatment4unknown_status
NCT04753034
Study of TER-101 Topical Ointment in Subjects With Atopic DermatitisNo drug interventionstreatment2completed
NCT02067234
A Psychoeducational Prevention for the Treatment of Atopic Dermatitis in Youth and Their FamiliesNo drug interventionspreventionNot Availablewithdrawn
NCT03948334
A Study to Assess the Safety and Efficacy of ZPL389 With TCS/TCI in Atopic Dermatitis PatientsNo drug interventionstreatment2terminated
NCT03250624
Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic Dermatitisother2completed
NCT03458624
Long-term Observational Study to Evalution the Safety and Efficacy of FURESTEM-AD Inj.No drug interventionsNot AvailableNot Availableunknown_status
NCT04553224
Collection of Clinical and Instrumental Data in Adult Subjects Suffering From Atopic DermatitisNo drug interventionsotherNot Availablecompleted
NCT03327116
Effect of Methotrexate on Inflammatory Response in Adult Atopic Dermatitis Patientsbasic_scienceNot Availablecompleted
NCT00121316
Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patientstreatment4completed
NCT03549416
BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients With Atopic DermatitisNo drug interventionsNot AvailableNot Availablerecruiting
NCT05451316
A Study to Assess Change in Disease Activity in Adolescents and Adults With Moderate to Severe Prurigo-type Atopic Dermatitis in Japan Who Are Treated With Oral UpadacitinibNo drug interventionsNot AvailableNot Availablerecruiting
NCT04633616
Tailored Patient-Provider Communication (TPPC): Evaluating the Impact of TPPC in Dermatology PatientsNo drug interventionsotherNot Availablecompleted
NCT06390696
Sand Play - the Effect of Biodiversity Exposure on Atopic DermatitisNo drug interventionstreatmentNot Availablerecruiting
NCT05432596
Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic DermatitisNo drug interventionstreatment2completed
NCT03770858
Wearable Skin Sensors to Assess Nocturnal Scratch BehaviorNot AvailableNot Availablecompleted
NCT05042258
Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitistreatment4not_yet_recruiting
NCT05125458
Relationships Among Inflammation, Physical and Mental Health in Subjects With Chronic Inflammatory Physical Diseases.No drug interventionsNot AvailableNot Availablecompleted
NCT04398758
Moisturizer Mediated Prevention of Symptoms of Atopic Dermatitis in Early ChildhoodNo drug interventionsprevention3unknown_status
NCT01805635
PF and FeNO and Clinical Characteristics in Children Being Diagnosed Due to Suspicion of Allergic DiseasesNo drug interventionsNot AvailableNot Availableunknown_status
NCT03936335
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)Not AvailableNot Availablerecruiting
NCT05688735
Assessment of the Effect of Coconut and Sunflower Seed Oil Derived Isosorbide Diseters and Colloidial OatmealNo drug interventionstreatmentNot Availablerecruiting
NCT00509535
Prospective, Randomized, Double Blind Comparative Study on the Use of Two Creams in Xerosis Atopic ProbandsNo drug interventionstreatmentNot Availablecompleted
NCT02094235
A Phase 1/2 Study of E6005 in Pediatric Subjects With Atopic Dermatitistreatment1 / 2completed
NCT05436535
Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysistreatment4recruiting
NCT06524635
A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumabbasic_science2recruiting
NCT03334435
A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitistreatment3completed
NCT04087863
Administration for Placebo Group and Evalution the Safety and Efficacy in Atopic Dermatitis PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT03809663
A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitistreatment2terminated
NCT01781663
Efficacy of KAM2904 Face Cream and KAM3008 Body Lotion Treatment in Children With Atopic Dermatitis (AD)No drug interventionstreatment4unknown_status
NCT01311986
Chemokine Expression in Nummular Dermatitis and Atopic DermatitisNo drug interventionsNot AvailableNot Availableunknown_status
NCT02260986
Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitistreatment3completed
NCT02647086
Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)basic_science1completed
NCT06004986
DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczematreatment4recruiting
NCT01045486
the Effectiveness of Probiotics on Atopic Dermatitis With Cow Milk AllergyNo drug interventionstreatmentNot Availablewithdrawn
NCT00914186
Study of TS-022 in Adult Patients With Atopic Dermatitis With Pruritus (POC)No drug interventionstreatment2completed
NCT05636839
UVB-induced Treg Cells Exert Antigen-specific Suppression Through LAG-3No drug interventionsbasic_scienceNot Availablerecruiting
NCT05140239
Effects of Abrocitinib Treatment on Skin Barrier FunctionNo drug interventionsNot AvailableNot Availablerecruiting
NCT03874039
Sweat and Gas Sensor for Healthy Skin and Atopic DermatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT05285839
Dupixent and Narrowband UVB for Atopic Dermatitistreatment4recruiting
NCT03976622
Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia AreataNot AvailableNot Availableunknown_status
NCT02950922
Study of RVT-501 in Adult and Adolescent Subjects With Atopic DermatitisNo drug interventionstreatment2completed
NCT05843422
A First-in-Human Study of QY211 Gel in Adult SubjectsNo drug interventionstreatment1recruiting
NCT03334422
Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitistreatment3completed
NCT02583022
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Atopic Dermatitistreatment2completed
NCT03903822
Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitistreatment2completed
NCT04240522
Prospective Longitudinal Observational Research in Atopic DermatitisNo drug interventionsNot AvailableNot Availableunknown_status
NCT02763722
Evaluating Results of Regularly Applied Emollient - Spray in Atopic Dermatitis TherapyNo drug interventionstreatmentNot Availableunknown_status
NCT05990725
Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitistreatment3recruiting
NCT03083730
Impact of Narrowband UVB Phototherapy on Systemic Inflammation in Patients With Atopic DermatitisNo drug interventionsbasic_scienceNot Availablecompleted
NCT00893230
A Study of a Probiotic in Atopic DermatitisNo drug interventionstreatment3completed
NCT01826630
A Study to Assess CLn® BodyWash for Reducing Skin Fauna in Patients With Hand EczemaNo drug interventionsbasic_scienceNot Availableterminated
NCT01244230
Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Atopic Dermatitis (AD)treatment2 / 3completed
NCT01544348
A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mLtreatment1completed
NCT02914548
Study of OPA-15406 Ointment in Patients With Atopic Dermatitistreatment2completed
NCT05502848
The Effect of Intervention and Mechanism of ICBT on Chronic Itching in Patients With Atopic DermatitisNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT01686048
The Significance of Ambrosia in Allergic Rhinitis and Asthma in IsraelNo drug interventionsNot AvailableNot Availablecompleted
NCT03131648
Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1)treatment3completed
NCT00903357
The Effectiveness of Montelukast on Atopic Dermatitis in KoreanstreatmentNot Availablecompleted
NCT01385657
Safety and Tolerability of Dupilumab in Participants With Moderate to Severe Atopic Dermatitistreatment1completed
NCT03464526
A Study of the Efficacy and Safety of Orvepitant in Subjects With Pruritus Associated With Atopic Dermatitistreatment2withdrawn
NCT02779426
Texting Atopic Dermatitis Patients to Optimize Learning and EASI ScoresNo drug interventionstreatmentNot Availablecompleted
NCT03091426
Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitistreatment2completed
NCT06116526
Dupilumab De-escalation in Pediatric Atopic Dermatitistreatment4recruiting
NCT03846466
Study of KHK 4323 in Healthy Volunteers and Subjects With Atopic DermatitisNo drug interventionstreatment1terminated
NCT03253666
Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component)No drug interventionsNot AvailableNot Availablecompleted
NCT00691366
Comprehensive Investigation of Heart Rate Variability as a Measure of the Autonomic Nervous System in Atopic DermatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT01177566
Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis.treatment4completed
NCT03632174
Evaluation and Comparison of 2 Cosmetic Investigational Products in Adults With Atopic DermatitisNo drug interventionsotherNot Availablecompleted
NCT05259774
Clinical Investigation on the Efficacy and Safety of Relizema Cream in Paedriatric PatientsNo drug interventionstreatmentNot Availablecompleted
NCT06330974
Allergy, Asthma, and Atopic Eczema in FinlandNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05142774
Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitistreatment3completed
NCT02532920
The Natural History of Atopic Disease in Thai Children and Association With Atopic MarchNo drug interventionsNot AvailableNot Availablecompleted
NCT05717920
A Clinical Trial in Subjects With Atopic Dermatitis (Part 1)No drug interventionstreatment2recruiting
NCT01993420
A Safety and Efficacy of DRM02 in Subjects With Atopic DermatitisNo drug interventionstreatment2completed
NCT05984420
Comparison of LimpiAD Cream 2.5% Plus Versus Its Vehicle and and a Basic Emollient in Patients With Atopic DermatitisNo drug interventionstreatmentNot Availablerecruiting
NCT05715320
Study of CM310 Injection in Subjects With Moderate-to-Severe Atopic Dermatitistreatment2recruiting
NCT05575882
Anti-relapse Efficacy and Tolerance Assessment of a Cosmetic Cream for Very Dry, Irritated to Atopic Sensitive Skin.No drug interventionspreventionNot Availablerecruiting
NCT05601882
A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitistreatment3completed
NCT05578482
Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitistreatment4recruiting
NCT01077882
Analysis of the Quality of Life, the Clinical Effectiveness and Cost-effectiveness of a Novel Educational Programme in Patients With Psoriasis and Atopic DermatitisNo drug interventionssupportive_care4completed
NCT04678882
Dupilumab in Japanese Patients With Atopic Dermatitistreatment3completed
NCT03415282
Open-Label Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic DermatitisNo drug interventionstreatment1unknown_status
NCT01905631
Blinded, Randomized Study Evaluating Aurstat Versus Control in the Treatment of Atopic Dermatitis Associated Pruritustreatment2completed
NCT00614731
Responses to Immunization With Keyhole Limpet Hemocyanin Administered by Scarification and the Intradermal Routebasic_science1completed
NCT04110873
A Phase II, Placebo-controlled Trial Evaluating the Efficacy of Antroquinonol in Patients With Atopic Dermatitistreatment2terminated
NCT00703573
A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 2 Doses of S-777469 in Patients With Atopic Dermatitistreatment2completed
NCT03898427
Scratch Behavior Under Standard of CareNo drug interventionsNot AvailableNot Availablecompleted
NCT03864627
A Study to Evaluate the Safety and Tolerability of MOR106 Administered Concomitantly With Topical Corticosteroids, in Adult Participants With Moderate to Severe Atopic DermatitisNo drug interventionstreatment2terminated
NCT01385527
Pediatric Atopic Dermatitis (AD) Internet Surveyhealth_services_researchNot Availablewithdrawn
NCT02347176
Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitistreatment2completed
NCT02126176
Protopic Adherence and Efficacy in Korean Eczema PatientNo drug interventionsNot AvailableNot Availablecompleted
NCT03089476
Evaluating Skin Barrier Dysfunction in Infants at High Risk of AtopyNo drug interventionsdiagnosticNot Availablewithdrawn
NCT00822276
The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA)No drug interventionsNot AvailableNot Availablecompleted
NCT02908360
Study of the Frequency and of the Regulatory Function of Positive T Lymphocytes Dual CD4CD8aa (DP8a) Specific to a Bacteria of the Intestinal Microbiota (Faecalibacterium Prausnitzii) in Atopic Dermatitis, Asthma and Allergic RhinitisNo drug interventionsNot AvailableNot Availablecompleted
NCT03983460
Dupilumab Impact on Skin Resident Memory T Cellsbasic_scienceNot Availableunknown_status
NCT05117060
Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic DermatitisNo drug interventionstreatment2completed
NCT00001760
Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy IndividualsNo drug interventionsNot AvailableNot Availablecompleted
NCT05455060
Effects of a Mixed Chinese Herbal Formula on Atopic DermatitisNo drug interventionstreatment3not_yet_recruiting
NCT02949960
DMT210 Topical Gel in the Treatment of Atopic DermatitisNo drug interventionstreatment2completed
NCT03823794
Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK)No drug interventionsNot AvailableNot Availableunknown_status
NCT06412094
Use of a Mobile Health App in Managing Pediatric Atopic DermatitisNo drug interventionssupportive_careNot Availablecompleted
NCT02932891
An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.No drug interventionstreatment2completed
NCT03831191
A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitistreatment2terminated
NCT04262791
A Non-Drug Study Detecting And Quantifying Nocturnal Scratch Behaviors From Wrist Actigraphy Data In Adult Healthy Volunteers And Participants With Atopic Dermatitis (AD)No drug interventionsdiagnostic1terminated
NCT04615962
Topical Cream SNG100 for Treatment in Moderate Atopic Dermatitis Subjects.treatment1unknown_status
NCT04137562
Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic DermatitisNo drug interventionstreatment2active_not_recruiting
NCT01806662
Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitistreatment2completed
NCT02153762
Treatment of Atopic Dermatitis With Different Orders of Application of Locoid Lotion and Hylatopic Plus CreamtreatmentNot Availablecompleted
NCT05613062
Modified Huang-Lian-Jie-Du Decoction (MHLJDD) for Atopic Dermatitis in ChildrenNo drug interventionstreatment1 / 2recruiting
NCT00789880
Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3treatment2completed
NCT02456480
Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitistreatment2completed
NCT04651829
Suspicion of Non IgE-mediated Cow's Milk Protein Allergy: Prevalence and EvolutionNo drug interventionsNot AvailableNot Availablecompleted
NCT01552629
A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patientstreatment2completed
NCT03689829
A Study to Test Safety, Tolerability, and the Way the Body Absorbs, Distributes, and Gets Rid of a Study Drug Called MOR106, in Healthy Subjects and in Patients With Moderate to Severe Atopic DermatitisNo drug interventionsbasic_science1terminated
NCT00980629
Dose-Finding Study of M516102 in the Treatment of Pruritus Associated With Atopic DermatitisNo drug interventionsNot Available2completed
NCT03961529
Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitistreatment3completed
NCT03089229
A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic DermatitisNo drug interventionstreatment1 / 2completed
NCT00723489
Immune Response to Yellow Fever Vaccination in Adults With Atopic Dermatitisbasic_science1 / 2completed
NCT04310189
The Role of IL-22/IL-22BP Axis in Atopic DermatitisNo drug interventionsotherNot Availablecompleted
NCT06448689
Analytical Validation of Wrist-Based Assessment of Nocturnal Scratch in Atopic Dermatitis and PsoriasisNo drug interventionsNot AvailableNot Availablerecruiting
NCT05114889
Safety and Tolerability of BSI-045B in Healthy Adult Subjects and Patients With Atopic Dermatitistreatment1completed
NCT03847389
Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitistreatment1 / 2terminated
NCT00710489
Potential Research Study Participant RegistryNo drug interventionsNot AvailableNot Availablecompleted
NCT00824889
Exploratory Study of Natural Killer Cells in Human SkinNo drug interventionsNot AvailableNot Availablecompleted
NCT03556592
Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4treatment1completed
NCT04435392
Jaktinib Hydrochloride Cream For Atopic Dermatitistreatment1 / 2completed
NCT04831892
The Effect of Isosorbide Diesters Based Moisturizer on Skin HealthNo drug interventionstreatmentNot Availablecompleted
NCT04040192
A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitistreatment3completed
NCT00826592
Comparison of Video-Based Versus Written Patient Education on Atopic DermatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT02589392
Cetaphil Restoraderm Effect on Young Children With Atopic DermatitisNo drug interventionspreventionNot Availablecompleted
NCT06216392
Phase III Study of GR1802 Injection in Patients With Atopic DermatitisNo drug interventionstreatment3not_yet_recruiting
NCT03011892
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitistreatment2completed
NCT04180644
Skin Tape Transcriptome Methods in ChildrenNo drug interventionsNot AvailableNot Availablecompleted
NCT06063044
Food-specific IgG4-guided Elimination Diets Improve Allergy Symptoms in ChildrenNo drug interventionsNot AvailableNot Availablecompleted
NCT03710044
Investigation of Flare and Remission in Subjects With Atopic Dermatitisother4withdrawn
NCT01291940
The Effects of Emollient Therapy on the Skin BarrierNo drug interventionspreventionNot Availablecompleted
NCT03252340
Safety of ADSTEM Injection in Patients With Moderate to Severe Subacute and Chronic Atopic DermatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT03736967
Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitistreatment2terminated
NCT03409367
A Community-based Assessment of Skin Care, Allergies, and EczemaNo drug interventionspreventionNot Availableactive_not_recruiting
NCT01469767
Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitistreatment2completed
NCT03733301
A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitistreatment3completed
NCT03826901
Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and Childrentreatment1completed
NCT02300701
Role of Anti-IgE in Severe Childhood Eczematreatment4completed
NCT03911401
Comparison Trial of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitistreatment3completed
NCT02896101
Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitistreatment3completed
NCT01548404
Study of Dupilumab in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitistreatment2completed
NCT05003804
Allergic Disease Onset Prevention StudyNo drug interventionsprevention1 / 2active_not_recruiting
NCT06345404
Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe ADtreatment1recruiting
NCT02888704
Safety and Efficacy of ADSTEM Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitistreatment1completed
NCT03646604
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitistreatment1active_not_recruiting
NCT04737304
A First-in-Human PoC Study With BEN2293 in Patients With Mild to Moderate Atopic DermatitisNo drug interventionstreatment1 / 2completed
NCT00550472
The Effect of a Probiotic Intervention in Healthy Subjects and Patients With Atopic DermatitisNo drug interventionstreatmentNot Availablecompleted
NCT02226068
Photophoresis Versus Ciclosporine in Severe Atopic DermatitistreatmentNot Availablecompleted
NCT05014568
Tapinarof for the Treatment of Atopic Dermatitis in Children and Adultstreatment3completed
NCT06383468
A Phase III Study to Evaluate the Efficacy and Safety of AK120 in Patients With Moderate to Severe Atopic DermatitisNo drug interventionstreatment3recruiting
NCT04728269
Exploratory Study on Lactibiane Topic AD on Skin Flora and Barrier Reinforcement in Mild to Moderate Atopic DermatitisNo drug interventionsbasic_scienceNot Availablecompleted
NCT04875169
Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitistreatment3completed
NCT05928169
Determinants of Chronic Inflammatory Skin Disease TrajectoriesNo drug interventionsNot AvailableNot Availablerecruiting
NCT04162769
A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitistreatment2completed
NCT02594969
The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic DermatitisNo drug interventionstreatmentNot Availablecompleted
NCT04472546
Use of the SpiderMass for in Vivo Analysis of the Skin in Five Chronic Inflammatory DermatosisNo drug interventionsbasic_scienceNot Availablecompleted
NCT02496546
An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)treatment1completed
NCT03831646
Clinical, Psychological and Genetic Characteristics in Dermatological PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT04992546
Phase 2a Study of the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic DermatitisNo drug interventionstreatment2completed
NCT04369846
A Phase I/IIa Study to Investigate the GM-XANTHO in Healthy Volunteers and Atopic Dermatitis PatientsNo drug interventionsother1 / 2recruiting
NCT05467046
Clinical Relevance of Scratching and Sleep in Atopic DermatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT06244212
Topical Treatment for Atopic DermatitisNo drug interventionshealth_services_researchNot Availablenot_yet_recruiting
NCT00828412
Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitistreatment4completed
NCT04763512
Clinical Study of Partially Hydrolysed Protein Infant Formula on Trans-epidermal Water Loss (TEWL)No drug interventionsotherNot Availablerecruiting
NCT00927212
Topical Application of AS101 for the Treatment of Atopic Dermatitistreatment2terminated
NCT04771910
Study of the Skin Microbiome and the Potential of a Topical Probiotic Cream for Atopic DermatitisNo drug interventionstreatmentNot Availableunknown_status
NCT04717310
Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Patients With Mild-to-Moderate Atopic Dermatitistreatment2 / 3active_not_recruiting
NCT02379910
A Study to Assess the Safety, Tolerability, PK and PD of AM1030-CREAM in Patients With Atopic DermatitisNo drug interventionstreatment1 / 2completed
NCT03832010
Steroid-reducing Effects of Crisaboroletreatment4completed
NCT01732510
A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003)No drug interventionstreatment1terminated
NCT01407510
HPA Axis Study in Japanese Adultstreatment2completed
NCT02677610
Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and OlderNo drug interventionstreatment3withdrawn
NCT00445081
Prednisolone vs. Ciclosporine in Severe Atopic Eczematreatment4completed
NCT00406081
Immune Response to Varicella Vaccination in Children With Atopic DermatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT00139581
Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric Subjectstreatment4completed
NCT03435081
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitistreatment3completed
NCT03916081
Safety and Efficacy of ARQ-151 Cream in Adolescents and Adults With Atopic Dermatitistreatment2completed
NCT01037881
LEO 29102 Cream in the Treatment of Atopic Dermatitistreatment2completed
NCT04927195
Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild AsthmaNo drug interventionstreatment1completed
NCT00583895
Safety and Efficacy Study of ImCOOH Cream in Patients Suffering From Moderate Atopic DermatitisNo drug interventionstreatment2terminated
NCT04693195
A Multiple-Dose Study of BLU-5937 in Chronic Pruritus Associated With Atopic Dermatitistreatment2completed
NCT03000595
A Trial of a Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic DermatitisNo drug interventionstreatment2withdrawn
NCT04352595
A Phase Ⅱ Study of Hemay808 for Atopic Dermatitis PatientsNo drug interventionstreatment2completed
NCT03260595
A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic Dermatitisbasic_science1completed
NCT06324695
Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEasesNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT01402414
Narrow-band (NB)-UVB vs. Bath-PUVA and NB-UVB Plus Salt Water Baths in Atopic DermatitisNo drug interventionstreatmentNot Availableterminated
NCT01065714
A Study to Investigate the Use of Hydrogel Vehicle in Maintaining the Skin Barrier in Persons With Atopic Dermatitistreatment4completed
NCT04271514
A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic DermatitisNo drug interventionstreatment1completed
NCT03742414
Seal, Stopping Eczema and Allergy Studyprevention2recruiting
NCT01122914
A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitistreatment1terminated
NCT03654755
Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitistreatment2terminated
NCT04564755
Abrocitinib Expanded Access Protocol in Adolescents and Adults With Moderate to Severe Atopic DermatitisNot AvailableNot Availableno_longer_available
NCT02840955
The Effect of Gladskin on Disease Severity and the Skin Microbiome, Including Staphylococcus Aureus, in Patients With Atopic DermatitisNo drug interventionstreatmentNot Availablecompleted
NCT04686955
The Efficacy of Patients With Moderate to Severe Atopic Dermatitis Treated With Chinese Herbal MedicineNo drug interventionstreatmentNot Availableunknown_status
NCT04504955
Corrona Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and EffectivenessNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT00654355
Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visittreatment4completed
NCT04001855
Evaluating the Effect of Bathing Additives in Atopic DermatitisNo drug interventionstreatmentNot Availableterminated
NCT04250350
Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitistreatment3completed
NCT01307150
Climatotherapy At The Dead Sea For Atopic DermatitisNo drug interventionsNot AvailableNot Availableunknown_status
NCT02449850
Preventing Atopic Dermatitis and ALLergies in ChildrenNo drug interventionspreventionNot Availableactive_not_recruiting
NCT00120523
5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitistreatment3completed
NCT04895423
Evaluation of the Effectiveness and Safety of Immunosuppressive and Biological Therapy of Atopic Dermatitis in Childhoodtreatment4unknown_status
NCT05265923
A Study of CM310 in Patients With Moderate-to-Severe Atopic Dermatitistreatment3recruiting
NCT01005823
A Safety, Tolerability and Pharmacokinetic Study of LEO 29102 in Subjects With Atopic DermatitisNo drug interventionstreatment1completed
NCT01605708
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic DermatitisNo drug interventionstreatment1 / 2terminated
NCT04287608
Observational Study of Conjunctivitis in the Setting of DUPIXENT® Treatment for Atopic DermatitisNot AvailableNot Availablecompleted
NCT02002208
Effect of OC000459 on Moderate to Severe Atopic Dermatitistreatment2completed
NCT00871208
Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapytreatment4withdrawn
NCT01635738
Probiotics and Allergic DiseasesNo drug interventionssupportive_careNot Availablecompleted
NCT03745638
Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitistreatment3completed
NCT02576938
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitistreatment2completed
NCT01232543
Safety Study Evaluating the Adrenal Suppression Potential of Product 0405 in Pediatric Subjects With Atopic DermatitisNo drug interventionstreatment2completed
NCT03376243
EARLYEMOLLIENT - Feasibility of Early Emollient Use in Children With Atopic EczemaNo drug interventionspreventionNot Availablecompleted
NCT05692843
Optimization of Cyclosporin in Atopic Dermatitis Through Multiomic Predictive Models of Treatment Responsetreatment4recruiting
NCT06509243
Dupilumab and House Dust Mite Immunotherapy in Patients With Atopic DermatitistreatmentNot Availablecompleted
NCT05608343
This Study is to Assess the Efficacy of Difamilast Ointment in Mild to Moderate Atopic Dermatitis(AD)treatment3completed
NCT04544943
Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Application of Topical BioLexa in Adult Healthy Subjects and Patients With Mild to Moderate Atopic Dermatitistreatment1completed
NCT00484003
A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic Dermatitistreatment4completed
NCT00771121
Effect of Moisturizing Creams on Skin Barrier FunctionNot Available4unknown_status
NCT00676884
A Phase 2a Study to Investigate the Effects of Repeated Administration of AeroDerm in Subjects With Atopic EczemaNo drug interventionstreatment2completed
NCT02381028
Topical Treatment With Fresh Human Milk Versus Emollient on Atopic Eczema Spots in Young ChildrenNo drug interventionstreatmentNot Availablecompleted
NCT00555178
Regulatory T Cells (Tregs) in Polymorphic Light EruptionNo drug interventionsNot AvailableNot Availablecompleted
NCT01854580
Evaluation of an Integrated Care ProjectNo drug interventionsNot AvailableNot Availablecompleted
NCT03143504
A Longitudinal Investigation of Skin Barrier Development From Birth and the Validation of Early Predictors of Atopic Eczema Risk: the Skin Testing for Atopic Eczema Risk (STAR) StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00559546
Montelukast as a Controller of Atopic Syndrometreatment4completed
NCT02915146
Narrowband Ultraviolet B Versus Narrowband Ultraviolet B Plus Ultraviolet A1 for Atopic EczemaNo drug interventionstreatmentNot Availablecompleted
NCT00576238
Skin Tolerance Study of Betamethasone Creams in Atopic Eczema and the Preventative Properties of a Moisturisertreatment3completed
NCT05590585
Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trialtreatment4active_not_recruiting
NCT01119313
Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic Eczematreatment2completed
NCT05454722
A Study to Evaluate Adex Gel in the Treatment of Atopic Eczema.No drug interventionsotherNot Availablecompleted
NCT03270566
Softened Water for Eczema Prevention Pilot TrialNo drug interventionspreventionNot Availableunknown_status
NCT06230991
A Pilot Study of Efficacy and Safety of SIM05 in Adults With Atopic EczemaNo drug interventionsotherNot Availableactive_not_recruiting
NCT06453512
A Study to Evaluate the Emollient Performance of Doublebase Once in the Treatment of Atopic EczemaNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT02087943
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitistreatment2completed
NCT02615249
Clinical Evaluation of Metal Panel Allergens: Dose Response StudyNo drug interventionsdiagnostic2completed
NCT05913791
Nutrients-fortified Egg Consumption on Eczema Condition in Individuals With EczemaNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT03050151
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitistreatment1completed
NCT05003453
The Effectiveness of a Topical Palmitoylethanolamide (PEA) Formulation (Levagen+) for Reducing Symptoms of Eczematreatment2 / 3completed
NCT04773600
Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II)treatment3completed
NCT04445298
Skin Barrier Assessment in Pregnancy and at BirthNo drug interventionsNot AvailableNot Availableunknown_status
NCT05136261
Evaluating the Efficacy and Tolerability of Ceradan Advanced Cream in the Treatment of Children With Atopic DermatitisNo drug interventionstreatment3unknown_status
NCT05918237
Pilot Study to Test the Effects of Arctiva on Mild to Moderate EczemaNo drug interventionstreatmentNot Availablecompleted
NCT03795506
TLA in Children With Moderate to Severe Atopic Eczema (TLA4AE)No drug interventionstreatmentNot Availablerecruiting
NCT04085549
Effects of a Berry Oil Cream on Atopic Eczema and SkinNo drug interventionstreatmentNot Availableterminated
NCT03859986
Study in Subjects With Moderate Atopic Dermatitistreatment2unknown_status
NCT03268174
Cosmetic Study to Improve the Appearance of Skin Afflicted With Mild to Moderate Atopic Dermatitis.No drug interventionsotherNot Availablecompleted
NCT04773587
Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic DermatitisNo drug interventionstreatment3completed
NCT04804605
Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic DermatitisNo drug interventionstreatment3completed
NCT05316805
China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment ProjectNo drug interventionsNot AvailableNot Availablerecruiting
NCT03090178
Sleep & Quality of Life Evaluation of Patients With Atopic Dermatitis Based on E-diary on a Smartphone Application and ActigraphyNo drug interventionsotherNot Availablecompleted
NCT05935085
This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects With Moderate to Severe Atopic Dermatitis (AD).No drug interventionstreatment2active_not_recruiting
NCT03386032
8-Week Atopic Dermatitis (AD) Treatment Studytreatment3completed
NCT06454942
Impact of Regular Consumption of Eggs and Nutrients Fortified Eggs on Eczema Condition in Singapore IndividualsNo drug interventionstreatmentNot Availablerecruiting
NCT05579899
Safety and Efficacy Study of EVO101 Topical Cream in Atopic DermatitisNo drug interventionstreatment2completed
NCT05382819
A Safety, Tolerability and Preliminary Efficacy Study of FRTX-02 Capsules in Healthy Subjects and Subjects With Atopic DermatitisNo drug interventionstreatment1terminated
NCT04500834
Metal Panel Allergen Patch Test StudyNo drug interventionsdiagnostic3recruiting
NCT03235024
Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic DermatitisNo drug interventionstreatment2completed
NCT04295824
Skin Pathology Assessment With Optical TechnologiesNo drug interventionsNot AvailableNot Availablecompleted
NCT04845620
Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (Integument-PED)No drug interventionstreatment3completed
NCT04017520
Breast Milk: Influence of the Micro-transcriptome Profile on Atopy in Children Over TimeNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04097327
Effect of Ectoin Dermatitis Cream 7% on Skin Hydration and Skin Barrier FunctionNo drug interventionsNot AvailableNot Availablecompleted
NCT01931644
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsNo drug interventionsNot AvailableNot Availablecompleted
NCT04537468
Development of a Method to Measure mRNA Levels in Skin SamplesNo drug interventionsotherNot Availablecompleted
NCT03158012
Evaluation of the Efficacy of an Autologous Microbiome Transplant in Adult Atopic Dermatitis PatientsNo drug interventionstreatment1completed
NCT03540043
Thykamine Safety and Efficacy Study in Mild-to-Moderate Atopic DermatitisNo drug interventionstreatment2completed
NCT06584552
LaCE (Lactobacillus Paracasei LPB27 On Early Childhood Eczema)No drug interventionstreatment2not_yet_recruiting
NCT00329784
Promoting Tolerance to Peanut in High-Risk ChildrenNo drug interventionstreatment2completed
NCT01899287
A Randomised Clinical Trial on the Effect of Group Education on Patients With Occupational Hand EczemaNo drug interventionspreventionNot Availablecompleted
NCT05873933
An Investigation of a Multi-Function Skincare Product to Improve Aging, Eczema, and Acne OutcomesNo drug interventionsotherNot Availablenot_yet_recruiting
NCT03667651
The PEBBLES Study - Testing a Strategy for Preventing Eczema and Food Allergy in High Risk InfantsNo drug interventionsprevention3active_not_recruiting
NCT05439577
A Multicentre Study to Explore the Efficacy and Safety of Mucopolysaccharide Polysulfate Cream in Patients With EczemaNot AvailableNot Availableunknown_status
NCT01420705
Bacille Calmette-Guérin (BCG) Vaccine and AtopyNo drug interventionsNot AvailableNot Availablecompleted
NCT04510961
Paraffin Bath Therapy for Chronic Hand EczemaNo drug interventionstreatmentNot Availablecompleted
NCT02002871
Blue Light for Treating EczemaNo drug interventionstreatmentNot Availablecompleted
NCT05770271
The Novel Electrolyzed Water Spray Treatment Mild Senile Groin Eczema, Neurodermatitis and PsoriasisNo drug interventionstreatmentNot Availablecompleted
NCT02075632
Study to Evaluate Product Duration of Use Experience With Alclometasone Dipropionate Creamtreatment2completed
NCT03134352
Study to Evaluate the Efficacy and Safety of ZL-3101 in Subjects With Subacute EczemaNo drug interventionstreatment2completed
NCT00519675
Alitretinoin in the Treatment of Chronic Hand Eczematreatment3completed
NCT00375713
Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizine) in Subjects With Dermatitis and Eczematreatment3completed
NCT00143819
Neuroskin Forte for Dry Skin Relief in Eczema and PsoriasisNo drug interventionstreatment2terminated
NCT00817063
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczematreatment3completed
NCT03406325
Mast Cell Activation Test in Allergic DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT04919330
Acceptance and Commitment Therapy-based Eczema Management ProgrammeNo drug interventionstreatmentNot Availablecompleted
NCT04214548
A Pilot Study to Explore the Role of Gut Flora in EczemaNo drug interventionsNot AvailableNot Availableunknown_status
NCT03192748
A Registry Study of Runzaozhiyang Capsule Used in Clinical Real WorldNo drug interventionsNot AvailableNot Availableunknown_status
NCT04919265
Mother-Infant Cohort Study in Malaysia and ChinaNo drug interventionsNot AvailableNot Availablerecruiting
NCT02536560
Intestinal Microbiota Composition After Antibiotic Treatment in Early LifeNo drug interventionsNot AvailableNot Availableunknown_status
NCT01779180
Vitamin A Supplementation at Birth and Atopy in ChildhoodNo drug interventionsNot AvailableNot Availableunknown_status
NCT01916980
Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Dermal Pruritus (MK-4117-202)treatment3completed
NCT06570889
VItamin D in pregnanCy for prevenTion Of eaRlY Childhood AsthmaNo drug interventionsprevention3not_yet_recruiting
NCT00713089
Study of Stool Microbiota in Two Diverse Cohorts of Asian and Its Influence on Allergy DevelopmentNo drug interventionsNot AvailableNot Availablecompleted
NCT01254240
Efficacy Study of Two Choices of Phototherapy on Itching Skin DiseasesNo drug interventionstreatment2completed
NCT02251340
Randomized Controlled Trial of an Eczema Care PlanNo drug interventionstreatmentNot Availablecompleted
NCT01366846
Persistence of Oral Tolerance to PeanutNo drug interventionstreatment2completed
NCT01143012
Group Eczema Education Visits:Impact on Patient and Family Quality of LifeNo drug interventionspreventionNot Availablecompleted
NCT06124781
Molecular Diagnosis of Allergic Contact Dermatitis (SMECA).No drug interventionsdiagnosticNot Availablerecruiting
NCT06583395
Quest to Analyze One Thousand Humans MeditatingNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT05413395
Assessment of the Effects on the Skin Microbiome of Amending an Over-the-counter Eczema Product With Activated Oil (AO)No drug interventionstreatmentNot Availableunknown_status
NCT00663364
Care of the Dry Skin With Physiogel AI Lotion® (W0156)No drug interventionssupportive_careNot Availablecompleted
NCT04986384
Effect of a Topical Spray on Itch Relief in Moderate-to-severe Childhood EczemaNo drug interventionstreatmentNot Availablecompleted
NCT06072287
The Living With a Long-Term Condition StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT02120833
A Test to Determine the Usefulness and Safety of a Cream Used on Babies With Dry Itchy SkinNo drug interventionstreatment3completed
NCT01012453
A Randomised Clinical Trial in a Population of Health Care Workers With Hand EczemaNo drug interventionspreventionNot Availableunknown_status
NCT01906853
Melbourne Infant Study - Bacille Calmette Guérin (BCG) for Allergy & Infection Reductionprevention3active_not_recruiting
NCT03871998
Short-term Topical Application to Prevent Atopic DermatitisNo drug interventionspreventionNot Availablecompleted
NCT01257061
Effectiveness of Clemastine Fumarate + Dexamethasone Compared to Dexchlorpheniramine Maleate in Eczema TreatmentNo drug interventionstreatment3completed
NCT03840928
PatientSpot Formerly Known as ArthritisPowerNo drug interventionsNot AvailableNot Availablerecruiting
NCT05607511
GB-EZ-SIM03 Probiotics Study for Childhood EczemaNo drug interventionstreatmentNot Availablecompleted
NCT02620293
A 47 Hour Occlusive Cutaneous Skin Patch Test on Adult Subjects With Dry/Atopic SkinNo drug interventionsNot Available1completed
NCT02404493
Test to Determine the Effectiveness of Moisturizing Balm Used on Babies With Dry, Itchy SkintreatmentNot Availableterminated
NCT03664271
Educational Eczema Video InterventionNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT04809571
Non-invasive Photoacoustic Imaging of Skin Inflammatory Disorders With Machine Learning-assisted ScoringNo drug interventionsdiagnosticNot Availableunknown_status
NCT05747378
Finding Patterns In Clinical Trial Experiences of Patients With EczemaNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02379507
DEC033 Study Product for Mild to Moderate Eczema An Open-label, Adaptive-design Pilot StudyNo drug interventionssupportive_care1completed
NCT05758532
Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Childrenprevention4recruiting
NCT02457000
Sleep, Circadian Rhythm & Skin HealthNo drug interventionsNot AvailableNot Availablecompleted
NCT03873142
The Effectiveness of a Mindful Parenting Intervention for Parents of Children With Psoriasis and Parents of Children With EczemaNo drug interventionstreatmentNot Availablecompleted
NCT00465699
Evaluation of Topical B12 for the Treatment of Childhood Atopic DermatitisNo drug interventionstreatmentNot Availableunknown_status
NCT01142999
Feasibility Study of Barrier Enhancement for Eczema PreventionpreventionNot Availableunknown_status
NCT04133506
PGE2/IL-22 Pathway in Various Forms of EczemaNot AvailableNot Availableunknown_status
NCT06155513
Omega-3 Monoglyceride Based Topic Products as Skin Prebiotics for Eczemabasic_scienceNot Availablerecruiting
NCT00894816
Probiotics in Prevention of Allergies, Obesity and CariesNo drug interventionspreventionNot Availablecompleted
NCT04471896
Joovvin' for Your Skin Health StudyNo drug interventionstreatmentNot Availablecompleted
NCT02533635
Ganoderma Tea on Eczema PatientNo drug interventionstreatment1 / 2unknown_status
NCT03738163
A Clinical Investigation With Epaderm® CreamNo drug interventionstreatmentNot Availablecompleted
NCT05473325
Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03160248
An Investigator-initiated Study of Apremilast to Demonstrate Efficacy Nummular Eczematreatment2completed
NCT03461848
CYPHP Evelina London EvaluationNo drug interventionshealth_services_researchNot Availablecompleted
NCT02517957
Xia Shi Surgical Treatment for Eczema Multi-center Clinical Researchtreatment2unknown_status
NCT00798226
Fish Oil Supplementation During Pregnancy for Prevention of Asthma, Eczema and Allergies in ChildhoodNo drug interventionsprevention1active_not_recruiting
NCT01498965
The Cork BASELINE Birth Cohort StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT04680520
Barrier Enhancement for Eczema PreventionNo drug interventionspreventionNot Availablecompleted
NCT01020994
Efficacy and Safety of LAS41003 in the Treatment of Superficial Infected Eczematreatment2completed
NCT06424691
Infant Restore: Efficacy of Microbiome Analysis and EducationNo drug interventionspreventionNot Availableactive_not_recruiting
NCT01429701
Effectiveness of Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol in Acute and Sub-acute Dermatitis Eczematoustreatment3completed
NCT04019769
Glutamine Supplementation in People With Immune Dysregulationtreatment0withdrawn
NCT00365469
Influence of Probiotics on Atopy, Immunological Responses and Gut Microflora - Follow-up to 5 YearsNo drug interventionsprevention2completed
NCT00438646
Oral Bacteria and Allergic Disease in ChildrenNo drug interventionsNot AvailableNot Availablecompleted
NCT01567995
Randomised, Double-blind, Placebo-controlled Study of Topical Clobetasone Butyrate 0.05% Cream in Subjects With Eczema for Two Weeks to Evaluate the Efficacy and Safetytreatment3completed
NCT00318695
Influence of Probiotics on Prevention of Atopy, Atopic Disease and Immunological ResponsesNo drug interventionsprevention2completed
NCT03340155
Mechanisms of Action of Photo(Chemo)Therapy in Skin DiseasesNo drug interventionsotherNot Availableunknown_status
NCT06560255
Fish Oil in pREgnancY for Personalized Prevention of Early Childhood AsthmaNo drug interventionsprevention3not_yet_recruiting
NCT01473823
Treatment of IgE Associated Eczema With Omega-3 Long Chain Polyunsaturated Fatty Acids in Infancy and the Development of Bronchial Asthma in ChildhoodNo drug interventionspreventionNot Availableunknown_status
NCT00924508
Hydrogel Patch for the Treatment of EczematreatmentNot Availableterminated
NCT04541810
A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablerecruiting
NCT05372653
A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitistreatment3completed
NCT04173442
Post-authorization Safety Study in North America to Monitor Pregnancy and Infant Outcomes Following Administration of Dupilumab During Planned or Unexpected PregnancyNot AvailableNot Availablerecruiting
NCT03168113
Atopic Dermatitis (AD) and Food AllergyNo drug interventionsNot AvailableNot Availablecompleted
NCT04056130
A Study of Single and Multiple Ascending Doses of KBL697 in Healthy SubjectsNo drug interventionstreatment1completed
NCT03151148
Targeted Microbiome Transplant in Atopic DermatitisNo drug interventionstreatment1 / 2completed
NCT05650320
To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients With ADtreatment3recruiting
NCT02357940
Tolerance Evaluation of a Nighttime Moisturizing Balm on Babies and Adults With EczematreatmentNot Availablecompleted
NCT04159597
Expanded Access to UpadacitinibNot AvailableNot Availableno_longer_available
NCT05959083
Real World Study of Oral Upadacitinib Tablets to Assess Adverse Events and Change in Disease Activity in Adolescent and Adult Chinese Participants With Atopic DermatitisNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03389893
Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitistreatment4terminated
NCT04666675
A Study of Oral Upadacitinib Tablets to Assess Change in Disease State in Participants Aged 12-75 Years With Moderate to Severe Atopic Dermatitis in Braziltreatment3withdrawn
NCT06503536
A Study to Assess Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization in Chinese Participants Receiving Upadacitinib for Atopic Dermatitis (AD) Through Chart ReviewNo drug interventionsNot AvailableNot Availablerecruiting
NCT01979016
Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)treatment2completed
NCT05456529
Study of Ruxolitinib Cream in Adolescents With Atopic Dermatitistreatment3completed
NCT05667623
To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With ADtreatment3recruiting
NCT06241118
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitortreatment3recruiting
NCT05492578
Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trialstreatment2 / 3recruiting
NCT05769777
Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitistreatment2recruiting
NCT06015308
A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebotreatment2recruiting
NCT06130566
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitistreatment3recruiting
NCT06181435
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)treatment3recruiting
NCT06224348
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroidstreatment3recruiting
NCT04718870
Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitistreatment4completed
NCT03992417
Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)Not AvailableNot Availableactive_not_recruiting
NCT05235724
A Study to Assess the Reliability/Feasibility of Using Emerald Touchless Sensor for Scratching and Sleep Quantification in a Subset of Participants From PEDISTAD Study (OBS15333; NCT03687359)No drug interventionsNot AvailableNot Availablecompleted
NCT04823130
Dupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic Dermatitisbasic_science4completed
NCT05214326
A Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Male and Female Participants of Atleast 12 Years Old Receiving Dupilumab Injections in Gulf CountriesNo drug interventionsNot AvailableNot Availablecompleted
NCT05983068
A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitistreatment4recruiting
NCT03687359
Observational Evaluation of Atopic Dermatitis in Pediatric PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT06407934
A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Monotherapy Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitistreatment3recruiting
NCT03849716
Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06192563
A Study to Observe How Adolescent Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions (Eczema Area and Severity Index Score < 16) Respond to Dupilumab TreatmentNot AvailableNot Availablerecruiting
NCT04135560
A Study To Determine The Safety, Tolerability, Skin Irritation Potential, And PK Following Topical Application Of PF-07038124 In Healthy Participantstreatment1completed
NCT04156191
Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate EczemaNo drug interventionstreatment1completed